ClickCease
+1-915-850-0900 spinedoctors@gmail.com
Select Page

Physical Rehabilitation

Back Clinic Physical Rehabilitation Team. Physical medicine and rehabilitation, which is also known as physiatry or rehabilitation medicine. Its goals are to enhance, restore functional ability and quality of life to those with physical impairments or disabilities affecting the brain, spinal cord, nerves, bones, joints, ligaments, muscles, and tendons. A physician that has completed training is referred to as a physiatrist.

Unlike other medical specialties that focus on a medical cure, the goals of the physiatrist are to maximize the patient’s independence in activities of daily living and improve quality of life. Rehabilitation can help with many body functions. Physiatrists are experts in creating a comprehensive, patient-centered treatment plan. Physiatrists are integral members of the team. They utilize modern, as well as, tried and true treatments to bring optimal function and quality of life to their patients. And patients can range from infants to octogenarians. For answers to any questions you may have please call Dr. Jimenez at 915-850-0900


Basic Phases of Treatment for Scoliosis

Basic Phases of Treatment for Scoliosis

When it comes to scoliosis treatment, most healthcare professionals follow a specific treatment plan, categorized by separate phases of treatment. The following are listed and described in detail below.

PHASE I – Pain Alleviation

While not all scoliosis sufferers experience pain or discomfort, a percentage do. In these patients the provision of treatment does help with individual compliance with prevention or corrective exercises.

Pain relief could be achieved through many different techniques:

  • electrotherapy modalities (ultrasound, TENs),
  • acupuncture,
  • release of tight muscles, and
  • supportive postural taping.

In this stage your healthcare specialist or professional, may also introduce mild exercises while your pain settles enhance your posture as well as to maintain in your backbone.

PHASE II – Rectifying Imbalances

Your healthcare physician will turn their attention to optimizing the strength and versatility of your muscles on either side of the scoliosis, as your pain and inflammation settles. They’ll also contain adjacent areas including the shoulder and hip area that could impact upon your alignment.

The principal remedy includes restoring regular spine array of motion, muscle length and tension through resting, muscle power, endurance and core balance. Taping methods could be employed until flexibility and adequate strength in the specific muscles has been achieved.

PHASE III – Restoring Complete Function

This scoliosis treatment phase is geared towards ensuring that you simply resume most of your typical daily activities, including sports and outdoor recreation without re-aggravation of your signs.

Depending on sport your chosen work or activities of everyday living living, your healthcare specialist will aim to restore your function to safely enable you to return to your activities.

Everyone has various needs because of their body that’ll determine specific treatment goals you require to achieve to what. For some it be simply to walk around the block. Others might desire to participate in a marathon. Your doctor will tailor your back rehabilitation to help attain your own practical goals.

PHASE IV – Preventing a Recurrence

Since scoliosis in several cases is a structural change in the skeleton, continuing self management is paramount to preventing re-exacerbation of your symptoms. This may entail a routine of a few key exercises to sustain versatility ideal strength, core balance and postural support. Your healthcare physician will assist you in determining which are the best exercises to carry on in the long-term.

In addition to your muscle manage, if you’d benefit from any exercises for some foot orthotics or adjacent muscles to address for bio-mechanical faults, your doctor will evaluate you hip bio-mechanics and decide. Some scoliosis results from an unequal leg size, which your therapist may possibly address with a heel rise, shoe rise or a built-up foot orthotic.

Rectifying these deficits and learning self management methods is crucial to maintaining continuing and perform participation in your daily and sports activities actions. You will be guided by your physiotherapist.

Treatment Result Expectations

You are able to expect a full return to normal daily, sporting and recreational activities in the event you have mild to moderate scoliosis. Your return to function is more promising if you are diagnosed and handled early.

In order to halt curve progression, individuals with more moderate to serious spinal curvatures may possibly need to be fitted for orthopedic braces. In certain severe circumstances throughout adolescence, surgery is indicated. Both of these latter two pathways are over seen by an orthopedic expert who might require monitoring the progress of the curve with program x-rays.

How to Treat Scoliosis (Video)

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900Green-Call-Now-Button-24H-150x150.png

By Dr. Alex Jimenez

Additional Topics: Scoliosis Pain and Chiropractic

According to recent research studies, chiropractic care and exercise can substantially help correct scoliosis. Scoliosis is a well-known type of spinal misalignment, or subluxation, characterized by the abnormal, lateral curvature of the spine. While there are two different types of scoliosis, chiropractic treatment techniques, including spinal adjustments and manual manipulations, are safe and effective alternative treatment measures which have been demonstrated to help correct the curve of the spine, restoring the original function of the spine.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: New PUSH 24/7�? Fitness Center

 

 

CHIROPRACTIC CARE FOR LOW BACK PAIN: CLINICAL PRACTICE GUIDELINE

CHIROPRACTIC CARE FOR LOW BACK PAIN: CLINICAL PRACTICE GUIDELINE

 Abstract

Objective

The purpose of this article is to provide an update of a previously published evidence-based practice guideline on chiropractic management of low back pain.

Methods

This project updated and combined 3 previous guidelines. A systematic review of articles published between October 2009 through February 2014 was conducted to update the literature published since the previous Council on Chiropractic Guidelines and Practice Parameters (CCGPP) guideline was developed. Articles with new relevant information were summarized and provided to the Delphi panel as background information along with the previous CCGPP guidelines. Delphi panelists who served on previous consensus projects and represented a broad sampling of jurisdictions and practice experience related to low back pain management were invited to participate. Thirty-seven panelists participated; 33 were doctors of chiropractic (DCs). In addition, public comment was sought by posting the consensus statements on the CCGPP Web site. The RAND-UCLA methodology was used to reach formal consensus.

Results

Consensus was reached after 1 round of revisions, with an additional round conducted to reach consensus on the changes that resulted from the public comment period. Most recommendations made in the original guidelines were unchanged after going through the consensus process.

Conclusions

The evidence supports that doctors of chiropractic are well suited to diagnose, treat, co-manage, and manage the treatment of patients with low back pain disorders.

Key Indexing Terms:

Chiropractic, Low Back Pain, Manipulation, Spinal, Guidelines

Early development of the chiropractic profession in the 1900s represented the application of accumulated wisdom and traditional practices.1, 2 As was the practice of medicine, philosophy and practice of chiropractic were informed to a large extent by an apprenticeship and clinical experiential model in a time predominantly absent of clinical trials and observational research.

The traditional chiropractic approach, in which a trial of natural and less invasive methods precedes aggressive therapies, has gained credibility. However, the chiropractic profession can gain wider acceptance in the role as the first point of contact health care provider to patients with low back disorders, particularly within integrated health care delivery systems, by embracing the scientific approach integral to evidence-based health care.3, 4, 5,6, 7 It is in this context that these guidelines were developed and are updated and revised.8, 9, 10, 11, 12

By today’s standards, it is the responsibility of a health profession to use scientific methods to conduct research and critically evaluate the evidence base for clinical methods used.13, 14 This scientific approach helps to ensure that best practices are emphasized.15 With respect to low back disorders, clinical experience suggests that some patients respond to different treatments. The availability of other clinical methods for conditions that are unresponsive to more evidence-informed approaches (primary nonresponders) introduces the opportunity for patients to achieve improved outcomes by alternative and personalized approaches that may be more attuned to individual differences that cannot be informed by typical clinical trials.16, 17, 18 To a large degree, variability in the selection of treatment methods among doctors of chiropractic (DCs) continues to exist, even though the large body of research on low back pain (LBP) has focused on the most commonly used manipulative methods.17, 19, 20

Although the weight of the evidence may favor the evidence referenced in a guideline for particular clinical methods, an individual patient may be best served in subsequent trials of care by treatment that is highly personalized to their own mechanical disorder, experience of pain and disability, as well as preference for a specific treatment approach. This is consistent with the 3 components of evidence-based practice: clinician experience and judgment, patient preferences and values, and the best available scientific evidence.3, 13

Doctors of chiropractic use methods that assist patients in self-management such as exercise, diet, and lifestyle modification to improve outcomes and their stabilization to avoid dependency on health care system resources.19, 21 They also recognize that a variety of health care providers play a critical role in the treatment and recovery process of patients at various stages, and that DCs should consult, refer patients, and co-manage patients with them when in the patient’s best interest.19

To facilitate best practices specific to the chiropractic management of patients with common, primarily musculoskeletal disorders, the profession established the Council on Chiropractic Guidelines and Practice Parameters (CCGPP) in 1995.6 The organization sponsored and/or participated in the development of a number of “best practices” recommendations on various conditions.21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 With respect to chiropractic management of LBP, a CCGPP team produced a literature synthesis8 which formed the basis of the first iteration of this guideline in 2008.9 In 2010, a new guideline focused on chronic spine-related pain was published,12 with a companion publication to both the 2008 and 2010 guidelines published in 2012, providing algorithms for chiropractic management of both acute and chronic pain.10 Guidelines should be updated regularly.33, 34 Therefore, this article provides the clinical practice guideline (CPG) based on an updated systematic literature review and extensive and robust consensus process.9, 10, 11, 12

Methods

This project was a guideline update based on current evidence and consensus of a multidisciplinary panel of experts in the conservative management of LBP. It has been recommended that, although periodic updates of guidelines are necessary, “partial updating often makes more sense than updating the whole CPG because topics and recommendations differ in terms of the need for updating.”33 Logan University Institutional Review Board determined that the project was exempt. We used Appraisal of Guidelines for Research & Evaluation (AGREE) in developing the guideline methodology.

Systematic Review

Between March 2014 through July 2014, we conducted a systematic review to update the literature published since the previous CCGPP guideline was developed. The search included articles that were published between October 2009 through February 2014. Our question was, “What is the effectiveness of chiropractic care including spinal manipulation for nonspecific low back pain?” Table 1 summarizes the eligibility criteria for the search.

Table 1

Eligibility Criteria for the Literature Search

Inclusion Exclusion
Published between October 2009-February 2014 Case reports and case series
English language Commentaries
Human participants Conference proceedings
Age >17 y In-patients
Manipulation Letters
LBP Narrative and qualitative reviews
Duration chronic (>3 mo) Non–peer-reviewed publications
Patient outcomes reported Pilot studies
Non-manipulation comparison group Pregnancy-related LBP
RCTs, cohort studies, systematic reviews, and meta-analyses Secondary analyses and descriptive studies

 

LBP, low back pain; RCT, randomized controlled trial.

Search Strategy

The following databases were included in the search: PubMed, Index to Chiropractic Literature, CINAHL, and MANTIS. Details of the strategy for each database are provided in Figure 1. Articles and abstracts were screened independently by 2 reviewers. Data were not further extracted.

 

 

 

 

 

 

 

Fig 1

Search strategies used in the literature search.

Evaluation of Articles

We evaluated articles using the Scottish Intercollegiate Guideline Network checklists (www.sign.ac.uk/methodology/checklists.html) for randomized controlled trials (RCTs) and systematic reviews/meta-analyses. For guidelines, the AGREE 2013 instrument35 was used. At least 2 of the 3 investigators conducting the review (CH, SW, MK) reviewed each article. If both reviewers rated the study as either high quality or acceptable, it was included for consideration; if both reviewers rated it as unacceptable, it was removed. For AGREE, we considered “unacceptable” to be a sum of <4. If there was disagreement between reviewers, a third also reviewed the article, and the majority rating was used.

Results of Literature Review

This search yielded 270 articles. Screening the articles for eligibility resulted in 18 articles included for evaluation, as detailed in Figure 2, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart.36

Fig 2

Flow diagram for literature search. LBP, low back pain; RCT, randomized controlled trial; SR, systematic reviews.

Of the 18 articles included after screening, 16 were retained as acceptable/high quality12, 17, 37, 38, 39, 40, 41, 42,43, 44, 45, 46, 47, 48, 49, 50 and 251, 52 (both systematic reviews) were excluded as being of unacceptable quality according to the Scottish Intercollegiate Guideline Network checklist. Those with new relevant information were summarized and provided to the Delphi panel as background information. Table 2 lists the articles by lead author and date, and the topic addressed, if new findings were present.

Table 2

Articles Evaluated

Lead Author Year Relevant New Findings
Guidelines and systematic reviews
Clar17 2014 None
Dagenais38 2010 Standards for assessment of LBP
Dagenais37 2010 Standards for assessment of LBP
Farabaugh12 2010 Basis for current update
Furlan39 2010 None
Goertz40 2012 None
Hidalgo41 2014 None
Koes42 2010 None
McIntosh43 2011 None
Posadzki44 2011 None
Rubinstein45 2013 None
Rubinstein46 2011
Excluded as unacceptable quality
Ernst51 2012
Menke52 2014
RCTs
Haas47 2013 Dosage information
Senna48 2011 Dosage information
Von Heymann49 2013 None
Walker50 2013 None

LBP, low back pain; RCT, randomized controlled trial.

Seed Documents & Seed Statements

Along with the literature summary, seed documents were comprised of the 3 previous CCGPP guidelines9, 10, 12; links were provided to full text versions. The original guidelines had been developed based on the evidence, including guidelines and research available at the time.16, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63 The steering committee, composed of authors on these previous guidelines, developed 51 seed statements based on the background documents, revising the previous statements if it seemed advisable based on the literature. The steering committee did not conduct a formal consensus process; however, the seed statement development was a team effort, with changes only made if all members of the steering committee were in agreement. Before conducting this project, these seed statements had gone through a local Delphi process among clinical and academic faculty at Logan University as part of their development of care pathways for their clinical faculty. This was done to assess the readability of the seed statements to a group of practicing clinicians. In the Delphi process, 7 statements were slightly modified from the original, and none of those changes were substantive, but rather for purposes of clarification. Consensus was reached for the seed document, which was then adopted by that institution for use in its teaching clinics. That document formed the seed document for the current project. For the Delphi rounds, the 51 statements were divided into 3 sections to be less onerous for the panelists to rate in a timely manner.

Delphi Panel

Panelists who served on the 3 previous consensus projects10, 11, 12 related to LBP management were invited to participate. Steering committee members made additional recommendations for experts in management of LBP who were not DCs to increase multidisciplinary input. There were 37 panelists; 33 were DCs, one of whom had dual licensure—DC and massage therapist. The 4 non-DC panelists consisted of an acupuncturist who is also a medical doctor, a medical doctor (orthopedic surgeon), a massage therapist, and a physical therapist. Thirty-three of the 37 panelists were in practice (89%); the mean number of years in practice was 27. Seventeen were also affiliated with a chiropractic institution (46%), with 2 of these associated with Logan University; 3 were affiliated with a different health care professional institution (8%); and 1 was employed with a government agency. Because this guideline focuses primarily on chiropractic practice in the United States, geographically, all panelists were from the United States, with 19 states represented. These were Arizona (1), California (4), Florida (3), Georgia (3), Hawaii (2), Iowa (2), Illinois (3), Kansas (1), Michigan (1), Minnesota (1), Missouri (3), North Carolina (1), New Jersey (2), New York (5), South Carolina (1), South Dakota (1), Texas (1), Virginia (1), and Vermont (1). Of the 33 DCs, 21 (64%) were members of the American Chiropractic Association, 2 (6%) were members of the International Chiropractors Association, and 10 (30%) did not belong to any national chiropractic professional organization.

Delphi Rounds and Rating System

The consensus process was conducted by e-mail. For purposes of analyzing the ratings and comments, panelists were identified by an ID number only. The Delphi panelists were not aware of other panelists’ identity during the duration of the study. As in our previous projects, we used the RAND-UCLA methodology for formal consensus.64

This methodology uses an ordinal scale of 1-9 (highly inappropriate to highly appropriate) to rate each seed statement. RAND/UCLA defines appropriateness to mean that expected patient health benefits are greater than expected negative effects by a large enough margin that the action is worthwhile, without considering costs.64

After scoring each Delphi round, the project coordinator provided the medians, percentages, and comments (as a Word table) to the steering committee. They reviewed all comments and revised any statements not reaching consensus as per these comments. The project coordinator circulated the revised statements, accompanied by the deidentified comments, to the Delphi panel for the next round.

We considered consensus on a statement’s appropriateness to have been reached if both the median rating was 7 or higher and at least 80% of panelists’ ratings for that statement were 7 or higher. Panelists were provided with space to make unlimited comments on each statement. If consensus could not be reached, it was planned that minority reports would be included.

Public Comments

As per recommendations for guideline development such as AGREE, we invited public comment on the draft CPG. This was accomplished by posting the consensus statement on the CCGPP Web site. Press releases and direct e-mail contacts announced a 2-week public comment period, with comments collected via an online Web survey application. Organizations and institutions who were contacted included the following: all US chiropractic colleges; members of all chiropractic state organizations; state boards of chiropractic examiners; chiropractic practice consultants; chiropractic attorneys; chiropractic media (including 1 publication sent to all US-licensed DCs); and chiropractic vendors, whose contacts also included interested laypersons. The steering committee then crafted additional or revised statements as per the comments collected through this method, and these statements were then recirculated through the Delphi panel until consensus was reached.

Data Analysis

For scoring purposes, ratings of 1-3 were collapsed as “inappropriate,” 4-6 as “uncertain,” and 7-9 as “appropriate.” If a panelist rated a statement as “inappropriate,” he or she was instructed to articulate a specific reason and provide a citation from the peer-reviewed literature to support it, if possible. The project coordinator entered ratings into a database (SPSS v. 22.0, Armonk, NY: IBM Corp, 2013).

Results

The verbatim evidence-informed consensus-based seed statements, as approved by the Delphi panel, are presented below. Consensus was reached after 1 round of revisions, with an additional round conducted to reach consensus on the changes that resulted from the public comment period. No minority reports are included because consensus was reached on all statements. There were 7 comments received, 6 from DCs and 1 from a layperson. Three did not require a response; statements were added or modified in response to the other 4 comments.

General Considerations

Most acute pain, typically the result of injury (micro- or macrotrauma), responds to a short course of conservative treatment (Table 3). If effectively treated at this stage, patients often recover with full resolution of pain and function, although recurrences are common. Delayed or inadequate early clinical management may result in increased risk of chronicity and disability. Furthermore, those responding poorly in the acute stage and those with increased risk factors for chronicity must also be identified as early as possible.

Table 3

Frequency and Duration for Trial(s) of Chiropractic Treatment

Stage Trials of Care Reevaluation
Acutea and subacutea 2-3× weekly, 2-4 wk 2-4 wk (per trial)
Recurrent/flare-up 1-3× weekly, 1-2 wk 1-2 wk
Chronicb 1-3× weekly, 2-4 wk 2-4 wk
 Exacerbation (mild) of chronicb 1-6 visits per episode At beginning of each episode of care
 Exacerbation (moderate or severe) of chronicb 2-3× weekly for 2-4 wk Every 2-4 wk, following acute care guidelines
 Scheduled ongoing care for management of chronic painb 1-4 visits per month At minimum every 6 visits, or as necessary to document condition changes.
aFor acute and subacute stages; up to 12 visits per trial of care. If additional trials of care are indicated, supporting documentation should be available for review, including, but not necessarily limited to, documentation of complicating factors and/or comorbidities coupled with evidence of functional gains from earlier trial(s). Efforts toward self-care recommendations should be documented.
bFor chronic presentations, exacerbations, and scheduled ongoing care for management of chronic pain, additional care must be supported with evidence of either functional improvement or functional optimization. Such presentations may include, but are not limited to, the following: (1) substantial symptom recurrences following treatment withdrawal, (2) minimization/control of pain, (3) maintenance of function and ability to perform common ADLs, (4) minimization of dependence on therapeutic interventions with greater risk(s) of adverse events, and (5) care which maintains or improves capacity to perform work. Efforts toward self-care recommendations should be documented.

Clinicians must continually be vigilant for the appearance of clinical red flags that may arise at any point during patient care. In addition, biopsychosocial factors (also known as clinical yellow flags) should be identified and addressed as early as possible as part of a comprehensive approach to clinical management.

Chiropractic doctors are skilled in multiple approaches of functional assessment and treatment. Depending on the clinical complexity, DCs can work independently or as part of a multidisciplinary team approach to functional restoration of patients with acute and chronic LBP.

It is the ultimate goal of chiropractic care to improve patients’ functional capacity and educate them to accept independently the responsibility for their own health.

Informed Consent

Informed consent is the process of proactive communication between a patient and physician that results in the patient’s authorization or agreement to undergo a specific medical intervention. Informed consent should be obtained from the patient and performed within the local and/or regional standards of practice. The DC should explain the diagnosis, examination, and proposed procedures clearly and simply and answer patients’ questions to ensure that they can make an informed decision about their health care choices. He or she should explain material risks* of care along with other reasonable treatment options, including the risks of no treatment. (*Note: The legal definition of material risk may vary state by state.)

Examination Procedures

Thorough history and evidence-informed examination procedures are critical components of chiropractic clinical management. These procedures provide the clinical rationale for appropriate diagnosis and subsequent treatment planning.

Assessment should include but is not limited to the following38:

  • Health history (eg, pain characteristics, red flags, review of systems, risk factors for chronicity)
  • Specific causes of LBP (eg, aortic aneurysm, inflammatory disorders)
  • Examination (eg, reflexes, dermatomes, myotomes, orthopedic tests)
  • Diagnostic testing (indications) for red flags (eg, imaging and laboratory tests)

Routine imaging or other diagnostic tests are not recommended for patients with nonspecific LBP.55

Imaging and other diagnostic tests are indicated in the presence of severe and/or progressive neurologic deficits or if the history and physical examination cause suspicion of serious underlying pathology.55

Patients with persistent LBP accompanied by signs or symptoms of radiculopathy or spinal stenosis should be evaluated, preferably, with magnetic resonance imaging or computed tomography.55

Imaging studies should be considered when patients fail to improve following a reasonable course of conservative care or when there is suspicion of an underlying anatomical anomaly, such as spondylolisthesis, moderate to severe spondylosis, posttrauma with worsening symptomatogy (consider imaging, referral, or co-management) with evidence of persistent or increasing neurological (ie, reflex, motor, and/or sensory) compromise, or other factors which might alter the treatment approach. Lateral view flexion/extension studies may be warranted to assess for mechanical instability due to excessive intervertebral translation and/or wedging. Imaging studies should be considered only after careful review and correlation of the history and examination.65

Severity and Duration of Conditions

Conditions of illness and injury are typically classified by severity and/or duration. Common descriptions of the stages of illness and injuries are acute, subacute, chronic, and recurrent, and further subdivided into mild, moderate, and severe.

  • Acute—symptoms persisting for less than 6 weeks.
  • Subacute—symptoms persisting between 6 and 12 weeks.
  • Chronic—symptoms persisting for at least 12 weeks’ duration.
  • Recurrent/flare-up—return of symptoms perceived to be similar to those of the original injury at sporadic intervals or as a result of exacerbating factors.

Treatment Frequency and Duration

Although most patients respond within anticipated time frames, frequency and duration of treatment may be influenced by individual patient factors or characteristics that present as barriers to recovery (eg, comorbidities, clinical yellow flags). Depending on these individualized factors, additional time and treatment may be required to observe a therapeutic response. The therapeutic effects of chiropractic care/treatment should be evaluated by subjective and/or objective assessments after each course of treatment (see “Outcome Measurement”).

Recommended therapeutic trial ranges are representative of typical care parameters. A typical initial therapeutic trial of chiropractic care consists of 6 to 12 visits over a 2- to 4-week period, with the doctor monitoring the patient’s progress with each visit to ensure that acceptable clinical gains are realized (Table 3).

For acute conditions, fewer treatments may be necessary to observe a therapeutic effect and to obtain complete recovery. Chiropractic management is also recommended for various chronic low back conditions where repeated episodes (or acute exacerbations) are experienced by the patient, particularly when a previous course of care has demonstrated clinical effectiveness and reduced the long-term use of medications.

Initial Course of Treatments for Low Back Disorders

To be consistent with an evidence-based approach, DCs should use clinical methods that generally reflect the best available evidence, combined with clinical judgment, experience, and patient preference. For example, currently, the most robust literature regarding manual therapy for LBP is based primarily on high-velocity, low-amplitude (HVLA) techniques, and mobilization (such as flexion-distraction).17, 20, 66 Therefore, in the absence of contraindications, these methods are generally recommended. However, best practices for individualized patient care, based on clinical judgment and patient preference, may require alternative clinical strategies for which the evidence of effectiveness may be less robust.

The treatment recommendations that follow, based on clinical experience combined with the best available evidence, are posited for the “typical” patient and do not include risk stratification for complicating factors. Complicating factors are discussed elsewhere in this document.

An initial course of chiropractic treatment typically includes 1 or more “passive” (ie, nonexercise) manual therapeutic procedures (ie, spinal manipulation or mobilization) and physiotherapeutic modalities for pain reduction, in addition to patient education designed to reassure and instill optimal strategies for independent management.

Although the evidence reviewed does not generally support the use of therapeutic modalities (ie, ultrasonography, electrical stimulation, etc) in isolation,67 their use as part of a passive-to-active care multimodal approach to LBP management may be warranted based on clinician judgment and patient preferences. Because of the scarcity of definitive evidence,68 lumbar supports (bracing/taping/orthoses) are not recommended for routine use, but there may be some utility in both acute and chronic conditions based upon clinician judgment, patient presentation, and preferences. Caution should be exercised as these orthopedic devices may interfere with conditioning and return to regular activities of daily living (ADLs).

The initial visits allow the doctor to explain that the clinician and the patient must work as a proactive team and to outline the patient’s responsibilities. Although passive care methods for pain or discomfort may be initially emphasized, “active” (ie, exercise) care should be increasingly integrated to increase function and return the patient to regular activities. Table 3 lists appropriate frequency and duration ranges for trials of chiropractic treatment for different stages of LBP.

Reevaluation & Reexamination

After an initial course of treatment has been concluded, a detailed or focused reevaluation should be performed. The purpose of this reevaluation is to determine whether the patient has made clinically meaningful improvement. A determination of the necessity for additional treatment should be based on the response to the initial trial of care and the likelihood that additional gains can be achieved.

As patients begin to plateau in their response to treatment, further care should be tapered or discontinued depending on the presentation. A reevaluation is recommended to confirm that the condition has reached a clinical plateau or has resolved. When a patient reaches complete or partial resolution of their condition and all reasonable treatment and diagnostic studies have been provided, then this should be considered a final plateau (maximum therapeutic benefit, MTB). The DC should perform a final examination, typically following a trial of therapeutic withdrawal, to verify that MTB has been achieved and provide any necessary patient education and instructions in effective future self-management and/or the possible need for future chiropractic care to retain the benefits achieved.

Continuing Course Of Treatment

If the criteria to support continuing chiropractic care (substantive, measurable functional gains with remaining functional deficits) have been achieved, a follow-up course of treatment may be indicated. However, one of the goals of any treatment plan should be to reduce the frequency of treatments to the point where MTB continues to be achieved while encouraging more active self-therapy, such as independent strengthening and range of motion exercises and rehabilitative exercises. Patients also need to be encouraged to return to usual activity levels as well as to avoid catastrophizing and overdependence on physicians, including DCs. The frequency of continued treatment generally depends on the severity and duration of the condition. Patients who are interested in wellness care (formerly called maintenance care11) should be given those options as well. (Wellness or maintenance care was defined by Dehen et al11 as “care to reduce the incidence or prevalence of illness, impairment, and risk factors and to promote optimal function.”)

When the patient’s condition reaches a plateau or no longer shows ongoing improvement from the therapy, a decision must be made on whether the patient will need to continue treatment. Generally, progressively longer trials of therapeutic withdrawal may be useful in ascertaining whether therapeutic gains can be maintained without treatment.

In a case where a patient reaches a clinical plateau in their recovery (MTB) and has been provided reasonable trials of interdisciplinary treatments, additional chiropractic care may be indicated in cases of exacerbation/flare-up or when withdrawal of care results in substantial, measurable decline in functional or work status. Additional chiropractic care may be indicated in cases of exacerbation/flare-up in patients who have previously reached MTB if criteria to support such care (substantive, measurable prior functional gains with recurrence of functional deficits) have been established.

Outcome Measurement

For a trial of care to be considered beneficial, it must be substantive, meaning that a definite improvement in the patient’s functional capacity has occurred. Examples of measurable outcomes and activities of daily living and employment include the following:

  • 1.Pain scales such as the visual analog scale and the numeric rating scale.
  • 2.Pain diagrams that allow the patient to demonstrate the location and character of their symptoms.
  • 3.Validated ADL measures, such as the Revised Oswestry Back Disability Index, Roland Morris Back Disability Index, RAND 36, and Bournemouth Disability Questionnaire.
  • 4.Increases in home and leisure activities, in addition to increases in exercise capacity.
  • 5.Increases in work capacity or decreases in prior work restrictions.
  • 6.Improvement in validated functional capacity testing, such as lifting capacity, strength, flexibility, and endurance.

Spinal Range Of Motion Assessment

Range of motion testing may be used as a part of the physical examination to assess for regional mobility, although evidence does not support its reliability in determining functional status.69

Benefit Vs Risk

Care rendered by DCs has been documented to be quite safe and effective compared with other common medical treatments and procedures. A 2010 systematic review concluded that serious adverse events were no more than 1 per million patient visits for lumbar spine manipulation.20 Another systematic review found that the risk of major adverse events with manual therapy is low, but many patients experience minor to moderate short-lived (<48 hours) adverse events after treatment.70

These are usually brief episodes of muscle stiffness or soreness.20 The relative risk (RR) of adverse events appears greater with drug therapy but less with usual medical care.70 Comparatively, an earlier study from 1995 related to cervical manipulation found that the RR for high-velocity manipulation causing minor/moderate adverse events was significantly less than the RR of the comparison medication (usually nonsteroidal anti-inflammatory drugs [NSAIDs]).71 The risk of death from NSAIDs for osteoarthritis was estimated to be 100-400 times the risk of death from cervical manipulation.71 Because lumbar spine manipulation is considered lower risk than cervical manipulation, it is reasonable to extrapolate that NSAIDs pose at least the same comparative risk when prescribed for the treatment of LBP. Special attention must be given to each patient’s individual history and presentation. In that context, it should be noted that for patients who are not good candidates for HVLA manipulation, DCs should modify their manual approach accordingly.

Cautions & Contraindications

Chiropractic-directed care, including patient education, and passive and active care therapy, is a safe and effective form of health care for low back disorders. As stated in the previous section, there are certain clinical situations where HVLA manipulation or other manual therapies may be contraindicated. It is incumbent upon the treating DC to evaluate the need for care and the risks associated with any treatment to be applied. Many contraindications are considered relative to the location and stage of severity of the morbidity, whether there is co-management with one or more specialists, and the therapeutic methods being used by the chiropractic physician. Figure 3 lists contraindications for high-velocity manipulation to the lumbar spine (red flags); however, these do not necessarily prohibit soft-tissue, low-velocity, low-amplitude procedures and mobilization.

 

Fig 3

Contraindications for high-velocity manipulation to the lumbar spine (red flags). aIn some cases, soft-tissue, low-velocity, low-amplitude mobilization procedures may still be clinically reasonable and safe.

Conditions Contraindicating Certain Chiropractic-Directed Treatments Such As Spinal Manipulation & Passive Therapy

In some complex cases where biomechanical, neurological, or vascular structure or integrity is compromised, the clinician may need to modify or omit the delivery of manipulative procedures. Chiropractic co-management may still be appropriate using a variety of treatments and therapies commonly used by DCs. It is prudent to document the steps taken to minimize the additional risk that these conditions may present. Figure 4 lists conditions which present contraindications to spinal manipulation and passive therapy, along with conditions requiring co-management and/or referral.

 

Fig 4

Conditions contraindicating certain chiropractic-directed treatments such as spinal manipulation and passive therapy.

During the course of ongoing chronic pain management of spine-related conditions, the provider must remain alert to the emergence of well-known and established “red flags” that could indicate the presence of serious pathology. Patients presenting with “red flag” signs and/or symptoms require prompt diagnostic workup which can include imaging, laboratory studies, and/or referral to another provider. Ignoring these “red flag” indicators increases the likelihood of patient harm. Figure 5 summarizes red flags that present contraindications to ongoing HVLA spinal manipulation.

 

Fig 5

Complicating factors that may document the necessity of ongoing care for chronic conditions.

Management of Chronic LBP

Definition of chronic pain patients. Note: MTB is defined as the point at which a patient’s condition has plateaued and is unlikely to improve further. Chronic pain patients are those for whom ongoing supervised treatment/care has demonstrated clinically meaningful improvement with a course of management and who have reached MTB, but in whom substantial residual deficits in activity performance remain or recur upon withdrawal of treatment. The management for chronic pain patients ranges from home-directed self-care to episodic care to scheduled ongoing care. Patients who require provider-assisted ongoing care are those for whom self-care measures, although necessary, are not sufficient to sustain previously achieved therapeutic gains; these patients may be expected to progressively deteriorate as demonstrated by previous treatment withdrawals.

Chronic Care Goals

  • Minimize lost time on the job
  • Support patient’s current level of function/ADL
  • Pain control/relief to tolerance
  • Minimize further disability
  • Minimize exacerbation frequency and severity
  • Maximize patient satisfaction
  • Reduce and/or minimize reliance on medication

Application of Chronic Pain Management

Chronic pain management occurs after the appropriate application of active and passive care including lifestyle modifications. It may be appropriate when rehabilitative and/or functional restorative and other care options, such as psychosocial issues, home-based self-care, and lifestyle modifications, have been considered and/or attempted, yet treatment fails to sustain prior therapeutic gains and withdrawal/reduction results in the exacerbation of the patient’s condition and/or adversely affects their ADLs.

Ongoing care may be inappropriate when it interferes with other appropriate care or when the risk of supportive care outweighs its benefits, that is, physician dependence, somatization, illness behavior, or secondary gain. However, when the benefits outweigh the risks, ongoing care may be both medically necessary and appropriate.

Appropriate chronic pain management of spine-related conditions includes addressing the issues of physician dependence, somatization, illness behavior, and secondary gain. Those conditions that require ongoing supervised treatment after having first achieved MTB should have appropriate documentation that clearly describes them as persistent or recurrent conditions. Once documented as persistent or recurrent, these chronic presentations should not be categorized as “acute” or uncomplicated.

Factors Affecting the Necessity for Chronic Pain Management of LBP

Prognostic factors that may provide a partial basis for the necessity for chronic pain management of LBP after MTB has been achieved include the following:

  • Older age (pain and disability)
  • History of prior episodes (pain, activity limitation, disability)
  • Duration of current episode >1 month (activity limitation, disability)
  • Leg pain (for patients having LBP) (pain, activity limitation, disability)
  • Psychosocial factors (depression [pain]; high fear-avoidance beliefs, poor coping skills [activity limitation]; expectations of recovery)
  • High pain intensity (activity limitation; disability)
  • Occupational factors (higher job physical or psychological demands [disability])

The list above is not all-inclusive and is provided to represent prognostic factors most commonly seen in the literature. Other factors or comorbidities not listed above may adversely affect a given patient’s prognosis and management. These should be documented in the clinical record and considered on a case-by-case basis.

Each of the following factors may complicate the patient’s condition, extend recovery time, and result in the necessity of ongoing care:

  • Nature of employment/work activities or ergonomics: The nature and psychosocial aspects of a patient’s employment must be considered when evaluating the need for ongoing care (eg, prolonged standing posture, high loads, and extended muscle activity)
  • Impairment/disability: The patient who has reached MTB but has failed to reach preinjury status has an impairment/disability even if the injured patient has not yet received a permanent impairment/disability award.
  • Medical history: Concurrent condition(s) and/or use of certain medications may affect outcomes.
  • History of prior treatment: Initial and subsequent care (type and duration), as well as patient compliance and response to care, can assist the physician in developing appropriate treatment planning. Delays in the initiation of appropriate care may complicate the patient’s condition and extend recovery time.
  • Lifestyle habits: Lifestyle habits may impact the magnitude of treatment response, including outcomes at MTB.
  • Psychological factors: A history of depression, anxiety, somatoform disorder, or other psychopathology may complicate treatment and/or recovery.

Treatment Withdrawal Fails to Sustain MTB

Documented flare-ups/exacerbations (ie, increased pain and/or associated symptoms, which may or may not be related to specific incidents), superimposed on a recurrent or chronic course, may be an indication of chronicity and/or need for ongoing care.

Complicating/Risk Factors for Failure to Sustain MTB

Figure 5 lists complicating factors that may document the necessity of ongoing care for chronic spine-related conditions. Such lists of complicating/risk factors are not all-inclusive. Individual factors from this list may adequately explain the condition chronicity, complexity, and instability in some cases. However, most chronic cases that require ongoing care are characterized by multiple complicating factors. These factors should be carefully identified and documented in the patient’s file to support the characterization of a condition as chronic.

Risk Factors for the Transition of Acute/Subacute Spine-Related Conditions to Chronicity (Yellow Flags)

A number of prognostic variables have been identified as increasing the risk of transition from acute/subacute to chronic nonspecific spine-related pain. However, their independent prognostic value is low. A multidimensional model, that is, a number of clinical, demographic, psychological, and social factors are considered simultaneously, has been recommended. This model emphasizes the interaction among these factors, as well as the possible overlap between variables such as pain beliefs and pain behaviors.

Chronicity may be described in terms of pain and/or activity limitation (function) and/or work disability. Risk factors for chronicity have been categorized by similar domains:

  • Symptoms
  • Psychosocial factors
  • Function
  • Occupational factors

Factors directly associated with the clinician/patient encounter may influence the transition to chronicity:

  • Treatment expectations: Patients with high expectations for a specific treatment may contribute to better functional outcomes if they receive that treatment.
  • Significant others’ support: Patients’ risk of chronicity may be reduced when family members encourage their participation in social and recreational activities.

Diagnosis Of Chronic LBP

The diagnosis should never be used exclusively to determine need for care (or lack thereof). The diagnosis must be considered with the remainder of case documentation to assist the physician or reviewer in developing a comprehensive clinical picture of the condition/patient under treatment.

Clinical Reevaluation Information

Clinical information obtained during reevaluation that may be used to document the necessity of chronic pain management for persistent or recurrent spine-related conditions includes, but is not limited to, the following:

  • Response to date of care management for the current and previous episodes.
  • Response to therapeutic withdrawal (either gradual or complete withdrawal) or absence of care.
  • MTB has been reached and documented.
  • Patient-centered outcome assessment instruments.
  • Analgesic use patterns.
  • Other health care services used.

Clinical Reevaluation Information to Document Necessity for Ongoing Care of Chronic LBP

In addition to standard documentation elements (ie, date, history, physical evaluation, diagnosis, and treatment plan), the clinical information typically relied upon to document the necessity of ongoing chronic pain management includes the following:

  • Documentation of having achieved a clinically meaningful favorable response to initial treatment or documentation that the plan of care is to be amended.
  • Documentation that the patient has reached MTB.
  • Substantial residual deficits in activity limitations are present at MTB.
  • Documented attempts of transition to primary self-care.
  • Documented attempts and/or consideration of alternative treatment approaches.
  • Documentation of those factors influencing the likelihood that self-care alone will be insufficient to sustain or restore MTB.

Once the need for additional care has been documented, findings of diagnostic/assessment procedures that may influence treatment selection include the following:

  • Neurological/provocative testing (standard neurological testing, orthopedic tests, manual muscle testing);
  • Diagnostic imaging (radiography, computed tomography, magnetic resonance imaging);
  • Electrodiagnostics;
  • Functional movement/assessment (eg, ambulatory assessment/limp);
  • Chiropractic analysis procedures;
  • Biomechanical analysis (pain, asymmetry, range of motion, tissue tone changes);
  • Palpation (static, motion);
  • Nutritional/dietary assessment with respect to factors related to pain management (such as vitamin D intake).

This list is provided for guidance only and is not all-inclusive. All items are not required to justify the need for ongoing care. Each item of clinical information should be documented in the case file to describe the patient’s clinical status, present and past.

In the absence of documented flare-up/exacerbation, the ongoing treatment of persistent or recurrent spine-related disorders is not expected to result in any clinically meaningful change. In the event of a flare-up or exacerbation, a patient may require additional supervised treatment to facilitate return to MTB status. Individual circumstances including patient preferences and previous response to specific interventions guide the appropriate services to be used in each case.

Chronic Pain Management Components in Physician-Directed Case Management

Case management of patients with chronic LBP should be based upon an individualized approach to care that combines the best evidence with clinician judgment and patient preferences. In addition to spinal manipulation and/or mobilization, an active care plan for chronic pain management may include, but is not restricted to, the following:

Procedures

  • Massage therapy
  • Other manual therapeutic methods
  • Physical modalities
  • Acupunctur
  • Bracing/orthoses

Behavioral and exercise recommendations

  • Supervised rehabilitative/therapeutic exercise
  • General and/or specific exercise programs
  • Mind/body programs (eg, yoga, Tai Chi)
  • Multidisciplinary rehabilitation
  • Cognitive behavioral programs

Counseling recommendations

  • ADL recommendations
  • Co-management/coordination of care with other physicians/health care providers
  • Ergonomic recommendations
  • Exercise recommendations and instruction
  • Home care recommendations
  • Lifestyle modifications/counseling
  • Pain management recommendations
  • Psychosocial counseling/behavioral modification/risk avoidance counseling
  • Monitoring patient compliance with self-care recommendations

Chronic Pain Management Treatment Planning

A variety of functional and physiological changes may occur in chronic conditions. Therefore, a variety of treatment procedures, modalities, and recommendations may be applied to benefit the patient. The necessity for ongoing chronic pain management of spine-related conditions for individual patients is established when there is a return of pain and/or other symptoms and/or pain-related difficulty performing tasks and actions equivalent to the appropriate minimal clinically important change value for more than 24 hours, for example, change in numeric rating scale of more than 2 points for chronic LBP.

Although the visit frequency and duration of supervised treatment vary and are influenced by the rate of recovery toward MTB values and the individual’s ability to self-manage the recurrence of complaints, a reasonable therapeutic trial for managing patients requiring ongoing care is up to 4 visits after a therapeutic withdrawal. If reevaluation indicates further care, this may be delivered at up to 4 visits per month. (Caution: The majority of chronic pain patients can self/home-manage, be managed in short episodic bursts of care, or require ongoing care at 1-2 visits per month, to be reevaluated at a minimum of every 12 visits. It is rare that a patient would require 4 visits per month to manage even advanced or complicated chronic pain.) Clinicians should routinely monitor a patient’s change in pain/function to determine appropriateness of continued care. An appropriate reevaluation should be completed at minimum every 12 visits. Reevaluation may be indicated more frequently in the event a patient reports a substantial or unanticipated change in symptoms and/or there is a basis for determining the need for change in the treatment plan/goals.

Scheduled Ongoing Chronic Pain Management Treatment Planning

When pain and/or ADL dysfunction exceeds the patient’s ability to self-manage, the medical necessity of care should be documented and the chronic care treatment plan altered appropriately.

Patient recovery patterns vary depending on degrees of exacerbations. Mild exacerbation episodes may be manageable with 1-6 office visits within a chronic care treatment plan. There is not a linear effect between the intensity of exacerbation and time to recovery.

Moderate and severe exacerbation episodes within a chronic care treatment plan require acute care recommendations and case management.12

Algorithms

Figure 6 summarizes the pathways for the chiropractic management of LBP.

 

Fig 6

Algorithms for chiropractic management of LBP.

Discussion

With the chiropractic profession’s establishment of the CCGPP to facilitate the development of best practices, 3 guidelines addressing the management of low back disorders were ultimately published.9, 10, 12 This set in motion an effort to improve clinical methods by reducing variation in chiropractic treatment patterns that has long been unaddressed by any other evidence-informed and consensus-driven official guideline.16, 54, 55, 62, 63,72 The approach to the development of these recommendations has been evolutionary so as to guide the profession toward the utilization of more evidence-informed clinical methods intended to improve patient outcomes. Historically, this also explains why the initial low back guideline, published in 2008, required 2 subsequent additional guidelines to expand on acute and chronic conditions. This was practical to introduce additional guidance in a stepwise fashion.

The focus of these recommendations has been patient centered and not practitioner centered. Practices and techniques that have not demonstrated superior efficacy in published studies may be used as alternative approaches to those methods that have more robust evidence. No other guidelines have been specific to this purpose within the chiropractic profession and endorsed as broadly, making this guideline unique. It is also important to consider that guidelines specific to other professions may or may not include clinical approaches that do not best inform chiropractic management of low back disorders. Although evidence produced under the auspices of other professions is important to consider, it is also important to consider whether this evidence informs a conservative care approach. For example, from a chiropractic viewpoint, drug and surgical treatment approaches are generally regarded as more invasive and should be considered as second- and third-line approaches to the treatment of low back disorders. That is why we believe that professional guidelines specific to a profession’s scope and approach to intervening in the natural course of disease are important.

It is the responsibility of a profession to periodically update guidelines to ensure consistency with new research findings and subsequent clinical experience. As such, an updated literature review was conducted, and the previous best practice guidelines were revised. The evidence reviewed has informed several important new recommendations to this updated guideline. For example, the evidence informs us that the routine use of radiographic imaging studies is not in the best interest of most patients with nonspecific LBP.53, 55 However, there may be exceptions to this based upon history and clinical examination characteristics. Doctors of chiropractic are advised that it is frequently in the best interest of patients to select manual method approaches that do not rely on radiographs to determine the method of manipulation or adjustment.69 In addition, it is not in the patient’s best interest for the DC to use the least evidence-informed chiropractic techniques as their first-line approach over those where the evidence is more robust.

While adding important new recommendations, it is useful to note that the updated literature synthesis did not ultimately require many other changes from the original guideline recommendations. The changes reflected in this current update were as follows: (1) a brief description of key elements that should standardly be included during an informed consent discussion; (2) the recommendation that routine radiographs, other imaging, and other diagnostic tests are not recommended for patients with nonspecific LBP (along with recommendations for when these studies should be considered); (3) recommendation that the hierarchy of clinical methods used in patient care should generally correspond to the supporting level of existing evidence; (4) additional clarification about the limited use of therapeutic modalities and lumbar supports that reflects patient preferences with the intention to best facilitate the shift from passive-to-active care and not dependency on passive modalities with limited evidence of efficacy; (5) recognition that although range of motion testing may be clinically useful as a part of the physical examination to assess for regional mobility, the evidence does not support its reliability in determining functional status; and (6) inclusion of a brief summary of the evidence informing manipulation risk vs benefit assessment.

Although this revision contemplates new guidance on key practice areas, it is not expected that these new recommendations will necessarily apply to every patient seen by a DC.

Similarly, with respect to the dosage recommendations (ie, treatment frequency and duration) within this guideline, dosage should be modified to fit the individual patient’s needs. For example, the majority of chronic pain patients can self-manage, can be managed in short episodic bursts of care, or require ongoing care at 1-2 visits per month, to be reevaluated at a minimum of every 12 visits. It is rare that a patient would require 4 visits per month to manage advanced or complicated chronic pain. Thus, it is important to consider this guideline’s recommendations for visit frequency as ranges rather than specific numbers. In addition, with regard to continuing assessments to evaluate the effectiveness of treatment, after the initial round of up to 6 visits, a brief evaluation should be performed to evaluate the progress of care. Such reevaluations at a minimum should include assessment of subjective and/or objective factors. These might include using pain scales such as the visual analog scale, the numeric rating scale, pain diagrams, and/or validated ADL measures, such as the Revised Oswestry Back Disability Index, Roland Morris Back Disability Index, RAND 36, or the Bournemouth Disability Questionnaire. Additional orthopedic/neurological tests may be considered on a case-by-case basis.

Nothing in this guideline should be interpreted as saying that patients should never have imaging ordered based upon examination and clinical judgment. Similarly, the conclusion should not be that every patient should only receive treatment methods with the highest level of evidence. It is the recommendation of this guideline that imaging and clinical methods have evidence to inform their use. In addition, patients should be informed when their care appears to require a trial of an alternate, less evidence-informed strategy.

Regarding the evidence used to support these guidelines, most clinical trials are limited in duration and usually reflect a target patient population that is not necessarily representative of all patients encountered in standard practice. Patients possess characteristics that include risk factors (ie, age, history of previous episodes of LBP, etc) and other clinical characteristics that were not specifically assessed in clinical trials. Therefore, it is important to view practice guidelines in this context and that a 1-size-fits-all approach will not fit all patients. It is the collective judgment of CCGPP, the Delphi panelists, and the authors that unexplainable and unnecessary variation in treatment patterns for standard presentations of nonspecific LBP, without considering or using the best evidence, will not necessarily lead to improvements in clinical methods and improved patient outcomes.

Future Studies

The work of developing and improving guidelines is a never-ending and time-consuming task. Therefore, the authors have suggested areas of patient management that should be considered during future revisions. Three areas suggested during the manuscript review process were (1) guidance on the evidence of the value of limited rest at various phases of recovery across the range of low back disorders, (2) more detailed guidance as to what history findings would/should lead to imaging, and (3) review of the literature describing efforts to develop assessment methods and tools to characterize the predictors of outcomes and inform selection and greater standardization of clinical methods.73, 74 Two areas of focus for future updates are also strongly recommended by the coauthors as well. The first concerns attempting to achieve a more detailed understanding of the hierarchy of chiropractic techniques that should be used based upon various archetypal patient presentations across the range of low back disorders. This would require reviewing head-to-head comparative research to determine relative efficacy of clinical methods using specific chiropractic techniques.

The authors recognize that some legacy outcome measures used in clinical practice and in clinical trials were not developed specifically with patients who may be interested in prioritizing conservative care approaches first. Also, because a measure’s ability to detect change and clinically minimal important difference (CMID) is linked directly to the target population and contextual characteristics, it is unlikely that there is a monolithic CMID value for a clinical outcomes assessment tool (including patient rated outcome measures) across all contexts of use and patient cohorts. More likely, there would be a range in CMID estimates that differs across varying patient cohorts and clinical trial contexts.75 The chiropractic profession has relied upon instruments that are less sensitive to changes in the types of risks, adverse effects, symptoms, and impacts that chiropractic patients might consider most important. This includes the benefits of avoidance of risks and adverse events associated with medication use and surgical interventions. As such, a comprehensive review is recommended to determine the evidence for the use of these legacy instruments in practice as well as, most critically, clinical trials that include the evaluation of the outcomes of the treatment of low back disorders that include chiropractic subjects. This type of review should include members who have a background in outcomes measurement and the development of de novo patient-reported outcomes instruments. Finally, an ever-broadening horizon of new and ongoing areas of related research constantly needs to be scanned for updated and applicable learnings, such as improved understanding of the interplay between functional anatomy (eg, muscular and fascial) and the generation of LBP.76, 77

Limitations

This guideline did not address several important issues that future efforts should focus on, including the following: the important issues of appropriate recommendations on limited rest; guidance on how DCs should assess history findings that might require imaging; expanded review and assessment of comparative efficacy of chiropractic manipulative techniques; and a full-scale review of outcome measures used by chiropractors and chiropractic researchers to evaluate the suitability of legacy measures as well as the robustness of their reported CMID in the context of populations frequently treated by chiropractors.78, 79, 80

Our Delphi panel may not have represented the broadest spectrum of DCs in terms of philosophy and approach to practice. In addition, this guideline is most applicable to chiropractic practice in the United States. Input from other professions was present but also limited to 4 members from other professions (acupuncture, massage therapy, medicine, and physical therapy). However, the panel had geographic diversity and was clearly based upon practice expertise with 33 of 37 panelists being in practice an average 27 years.

Another limitation relates to the literature included in the systematic review, which extended through February 2014 to provide time for project implementation. It is possible that articles were inadvertently excluded. An important issue related to the literature is that issues of great practical importance, such as the determination of optimal procedures and protocols for specific patients, do not yet have enough high-quality evidence to make detailed recommendations. An example of this is the use of a wide variety of manipulative techniques by DCs,19even though most randomized trials use only HVLA manipulation, due to the requirements of the study design for uniformity of the intervention. As the evidence base for manipulative techniques grows and expands its scope, it is essential that CPGs continue to be updated in response to new evidence. Although the authors did not task themselves with the responsibility of developing a formal dissemination plan, CCGPP is currently developing one to coordinate with the timing of the publication of this guideline.

Finally, any guideline recommendations are limited by those who would use partial statements, out of context, to justify a treatment, utilization, and/or reimbursement decision. It is critical to the appropriate use of this CPG that recommendations are not misconstrued by being taken out of context by the use of partial statements. To avoid such practice, we strongly recommend that when a quote from this guideline is to be used, an entire paragraph be included to contextualize the recommendation being cited.

Conclusion

This publication is an update of the best practice recommendations for chiropractic management of LBP.9, 10, 12This guide summarizes recommendations throughout the continuum of care from acute to chronic and offers the chiropractic profession and other key stakeholders an up-to-date evidence- and clinical practice experience–informed resource outlining best practice approaches for the treatment of patients with LBP.

Funding Sources & Conflicts of Interest

All authors and panelists participated without compensation from any organization. Logan University made an in-kind contribution to the project by allowing Drs. Hawk and Kaeser and Ms. Anderson and Walters to devote a portion of their work time to this project. The University of Western States also provided in-kind support for a portion of Dr. Hawk’s time. Dr. Farabaugh currently holds the position of the National Physical Medicine Director of Advanced Medical Integration Group, LP. Dr. Morris is a post-graduate faculty member of the National University of Health Sciences and receives access to library resources. There were no conflicts of interest were reported for this study.

Contributorship Information

  • Concept development (provided idea for the research): C.H., G.G., C.M., W.W., G.B.
  • Design (planned the methods to generate the results): C.H., G.G.
  • Supervision (provided oversight, responsible for organization and implementation, writing of the manuscript): C.H., G.G., C.M.
  • Data collection/processing (responsible for experiments, patient management, organization, or reporting data): C.H.
  • Analysis/interpretation (responsible for statistical analysis, evaluation, and presentation of the results): C.H., G.G., C.M., G.B.
  • Literature search (performed the literature search): C.H., M.K., S.W., R.F., G.G., C.M.
  • Writing (responsible for writing a substantive part of the manuscript): C.H., R.F., G.G., C.M., W.W., G.B.
  • Critical review (revised manuscript for intellectual content; this does not relate to spelling and grammar checking): C.H., M.K., S.W., R.F., M.D., G.G., C.M., W.W., M.D., G.B., T.A.

Acknowledgment

The authors thank Michelle Anderson, project coordinator, who ensured that all communications were completed smoothly and in a timely manner. The experts, listed below, who served on the Delphi panel made this project possible by generously donating their expertise and clinical judgment.

Logan University panelists who developed the seed document that served as the basis for the consensus process: Robin McCauley Bozark, DC; Karen Dishauzi, DC, MEd; Krista Gerau, DC; Edward Johnnie, DC; Aimee Jokerst, DC; Jeffrey Kamper, DC; Norman Kettner, DC; Janine Ludwinski, DC; Donna Mannello, DC; Anthony Miller, DC; Patrick Montgomery, DC; Michael J. Wittmer, DC. Muriel Perillat, DC, MS, Logan Dean of Clinics, also provided an independent review of the document.

Delphi panelists for the consensus process: Charles Blum, DC; Bryan Bond, DC; Jeff Bonsell, DC; Jerrilyn Cambron, LMT, DC, MPH, PhD; Joseph Cipriano, DC; Mark Cotney, DC; Edward Cremata, DC; Don Cross, DC; Donald Dishman, DC; Gregory Doerr, DC; Paul Dougherty, DC; Joseph Ferstl, DC; Anthony Q. Hall, DC; Michael W. Hall, DC; Robert Hayden, DC, PhD; Kathryn Hoiriis, DC; Lawrence Humberstone, DC; Norman Kettner, DC; Robert Klein, DC; Kurt Kuhn, DC, PhD; William Lauretti, DC; Gene Lewis, DC, MPH; John Lockenour, DC; James McDaniel, DC; Martha Menard, PhD, LMT; Angela Nicholas, DC; Mariangela Penna, DC; Dan Spencer, DC; Albert Stabile, DC; John S. Stites, DC; Kasey Sudkamp, DPT; Leonard Suiter, DC; John Ventura, DC; Sivarama Vinjamury, MD, MAOM, MPH, LAc; Jeffrey Weber, MA, DC; Gregory Yoshida, MD.

References

  1. Meeker, S HW. Chiropractic: a profession at the crossroads of mainstream and alternative medicine. Ann Intern Med. 2002; 136: 216–227
  2. Coulter, I. The roles of philosophy and belief systems in complementary and alternative health care.in: Paper presented at: Conference on Philosophy of Chiropractic Education 2000; Toronto. ; 2000
  3. LeFebvre, R, Peterson, D, and Haas, M. Evidence-based practice and chiropractic care. JEBCAM. 2013; 18: 75–79
  4. Triano, J and Raley, B. Chiropractic in the interdisciplinary team practice. Top Clin Chiropr. 1994; 1: 58–66
  5. Triano, JJ. Literature syntheses for the Council on Chiropractic Guidelines and Practice Parameters: methodology. J Manipulative Physiol Ther. 2008; 31: 645–650
  6. Triano, JJ. What constitutes evidence for best practice?. J Manipulative Physiol Ther. 2008; 31: 637–643
  7. Triano, JJ, Goertz, C, Weeks, J et al. Chiropractic in North America: toward a strategic plan for professional renewal—outcomes from the 2006 Chiropractic Strategic Planning Conference. J Manipulative Physiol Ther. 2010; 33: 395–405
  8. Lawrence, DJ, Meeker, W, Branson, R et al. Chiropractic management of low back pain and low back-related leg complaints: a literature synthesis. J Manipulative Physiol Ther. 2008; 31: 659–674
  9. Globe, GA, Morris, CE, Whalen, WM, Farabaugh, RJ, and Hawk, C. Chiropractic management of low back disorders: report from a consensus process. J Manipulative Physiol Ther. 2008; 31: 651–658
  10. Baker, G, Farabaugh, RJ, Augat, TJ, and Hawk, C. Algorithms for the chiropractic management of acute and chronic spine-related pain. Top Integr Health Care. 2012; 3
  11. Dehen, MD, Whalen, WM, Farabaugh, RJ, and Hawk, C. Consensus terminology for stages of care: acute, chronic, recurrent, and wellness. J Manipulative Physiol Ther. 2010; 33: 458–463
  12. Farabaugh, RJ, Dehen, MD, and Hawk, C. Management of chronic spine-related conditions: consensus recommendations of a multidisciplinary panel. J Manipulative Physiol Ther. 2010; 33: 484–492
  13. Sackett, DL, Rosenberg, WM, Gray, JA, Haynes, RB, and Richardson, WS. Evidence based medicine: what it is and what it isn’t. BMJ. 1996; 312: 71–72
  14. Sackett, DL, Straus, SE, Richardson, WS et al. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Church Livingston, Edinburgh; 2000
  15. Slaughter, AL, Frith, K, O’Keefe, L, Alexander, S, and Stoll, R. Promoting best practices for managing acute low back pain in an occupational environment. Workplace Health Saf. 2015; 63: 408–414
  16. Haldeman, S and Dagenais, S. What have we learned about the evidence-informed management of chronic low back pain?. Spine J. 2008; 8: 266–277
  17. Clar, C, Tsertsvadze, A, Court, R, Hundt, GL, Clarke, A, and Sutcliffe, P. Clinical effectiveness of manual therapy for the management of musculoskeletal and non-musculoskeletal conditions: systematic review and update of UK evidence report. Chiropr Man Ther. 2014; 22: 12
  18. Council on Chiropractic Education. Accreditation standards, principles, processes & requirements for accreditation. (Scottsdale, AZ); 2013
  19. Christensen, M, Kollasch, M, and Hyland, JK. Practice analysis of chiropractic. NBCE, Greeley, CO; 2010
  20. Bronfort, G, Haas, M, Evans, R, Leiniger, B, and Triano, J. Effectiveness of manual therapies: the UK evidence report. Chiropr Osteopath. 2010; 18: 3
  21. Hawk, C, Schneider, M, Evans, MW, and Redwood, D. Consensus process to develop a best-practice document on the role of chiropractic care in health promotion, disease prevention, and wellness. J Manipulative Physiol Ther. 2012; 35: 556–567
  22. Hawk, C, Khorsan, R, Lisi, AJ, Ferrance, RJ, and Evans, MW. Chiropractic care for nonmusculoskeletal conditions: a systematic review with implications for whole systems research. J Altern Complement Med. 2007; 13: 491–512
  23. Hawk, C, Schneider, M, Dougherty, P, Gleberzon, BJ, and Killinger, LZ. Best practices recommendations for chiropractic care for older adults: results of a consensus process. J Manipulative Physiol Ther. 2010; 33: 464–473
  24. Hawk, C, Schneider, M, Ferrance, RJ, Hewitt, E, Van Loon, M, and Tanis, L. Best practices recommendations for chiropractic care for infants, children, and adolescents: results of a consensus process. J Manipulative Physiol Ther. 2009; 32: 639–647
  25. Schneider, M, Vernon, H, Ko, G, Lawson, G, and Perera, J. Chiropractic management of fibromyalgia syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009; 32: 25–40
  26. Vernon, H and Schneider, M. Chiropractic management of myofascial trigger points and myofascial pain syndrome: a systematic review of the literature. J Manipulative Physiol Ther. 2009; 32: 14–24
  27. Pfefer, MT, Cooper, SR, and Uhl, NL. Chiropractic management of tendinopathy: a literature synthesis. J Manipulative Physiol Ther. 2009; 32: 41–52
  28. Brantingham, JW, Bonnefin, D, Perle, SM et al. Manipulative therapy for lower extremity conditions: update of a literature review. J Manipulative Physiol Ther. 2012; 35: 127–166
  29. Brantingham, JW, Cassa, TK, Bonnefin, D et al. Manipulative therapy for shoulder pain and disorders: expansion of a systematic review. J Manipulative Physiol Ther. 2011; 34: 314–346
  30. Brantingham, JW, Cassa, TK, Bonnefin, D et al. Manipulative and multimodal therapy for upper extremity and temporomandibular disorders: a systematic review. J Manipulative Physiol Ther. 2013;36: 143–201
  31. Brantingham, JW, Globe, G, Pollard, H, Hicks, M, Korporaal, C, and Hoskins, W. Manipulative therapy for lower extremity conditions: expansion of literature review. J Manipulative Physiol Ther. 2009; 32: 53–71
  32. Brantingham, JW, Parkin-Smith, G, Cassa, TK et al. Full kinetic chain manual and manipulative therapy plus exercise compared with targeted manual and manipulative therapy plus exercise for symptomatic osteoarthritis of the hip: a randomized controlled trial. Arch Phys Med Rehabil. 2012; 93: 259–267
  33. Becker, M, Neugebauer, EA, and Eikermann, M. Partial updating of clinical practice guidelines often makes more sense than full updating: a systematic review on methods and the development of an updating procedure. J Clin Epidemiol. 2014; 67: 33–45
  34. Shekelle, P, Woolf, S, Grimshaw, JM, Schunemann, HJ, and Eccles, MP. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci. 2012; 7: 62
  35. The AGREE Next Steps Consortium. Appraisal of guidelines for research and evaluation II. ([Ontario, Canada]); 2013
  36. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, and Group, P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535
  37. Dagenais, S, Gay, RE, Tricco, AC, Freeman, MD, and Mayer, JM. NASS contemporary concepts in spine care: spinal manipulation therapy for acute low back pain. Spine J. 2010; 10: 918–940
  38. Dagenais, S, Tricco, AC, and Haldeman, S. Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines. Spine J. 2010; 10: 514–529
  39. Furlan, AD, Yazdi, F, Tsertsvadze, A et al. Complementary and alternative therapies for back pain II.Evid Rep Technol Assess (Full Rep). 2010; : 1–764
  40. Goertz, CM, Pohlman, KA, Vining, RD, Brantingham, JW, and Long, CR. Patient-centered outcomes of high-velocity, low-amplitude spinal manipulation for low back pain: a systematic review. J Electromyogr Kinesiol. 2012; 22: 670–691
  41. Hidalgo, B, Detrembleur, C, Hall, T, Mahaudens, P, and Nielens, H. The efficacy of manual therapy and exercise for different stages of non-specific low back pain: an update of systematic reviews. J Man Manip Ther. 2014; 22: 59–74
  42. Koes, BW, van Tulder, M, Lin, CW, Macedo, LG, McAuley, J, and Maher, C. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010; 19: 2075–2094
  43. McIntosh, G and Hall, H. Low back pain (acute). BMJ Clin Evid. 2011; 2011
  44. Posadzki, P and Ernst, E. Spinal manipulations for cervicogenic headaches: a systematic review of randomized clinical trials. Headache. 2011; 51: 1132–1139
  45. Rubinstein, SM, Terwee, CB, Assendelft, WJ, de Boer, MR, and van Tulder, MW. Spinal manipulative therapy for acute low back pain: an update of the cochrane review. Spine (Phila Pa 1976). 2013; 38: E158–E177
  46. Rubinstein, SM, van Middelkoop, M, Assendelft, WJ, de Boer, MR, and van Tulder, MW. Spinal manipulative therapy for chronic low-back pain: an update of a Cochrane review. Spine (Phila Pa 1976). 2011; 36: E825–E846
  47. Haas, M, Vavrek, D, Peterson, D, Polissar, N, and Neradilek, MB. Dose-response and efficacy of spinal manipulation for care of chronic low back pain: a randomized controlled trial. Spine J. 2014;14: 1106–1116
  48. Senna, MK and Machaly, SA. Does maintained spinal manipulation therapy for chronic nonspecific low back pain result in better long-term outcome?. Spine (Phila Pa 1976). 2011; 36: 1427–1437
  49. von Heymann, WJ, Schloemer, P, Timm, J, and Muehlbauer, B. Spinal high-velocity low amplitude manipulation in acute nonspecific low back pain: a double-blinded randomized controlled trial in comparison with diclofenac and placebo. Spine (Phila Pa 1976). 2013; 38: 540–548
  50. Walker, BF, Hebert, JJ, Stomski, NJ, Losco, B, and French, SD. Short-term usual chiropractic care for spinal pain: a randomized controlled trial. Spine (Phila Pa 1976). 2013; 38: 2071–207
  51. Ernst, E. Chiropractic spinal manipulation: what does the ‘best’ evidence show?. Focus Altern Complement Ther. 2012; 17: E463–E472
  52. Menke, JM. Do manual therapies help low back pain? A comparative effectiveness meta-analysis.Spine (Phila Pa 1976). 2014; 39: E463–E472
  53. Chou, R, Fu, R, Carrino, JA, and Deyo, RA. Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet. 2009; 373: 463–472
  54. Chou, R and Huffman, LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007; 147: 492–504
  55. Chou, R, Qaseem, A, Snow, V et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007; 147: 478–491
  56. Chou, WC, Tinetti, ME, King, MB, Irwin, K, and Fortinsky, RH. Perceptions of physicians on the barriers and facilitators to integrating fall risk evaluation and management into practice. J Gen Intern Med. 2006; 21: 117–122
  57. Guzman, J, Haldeman, S, Carroll, LJ et al. Clinical practice implications of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders: from concepts and findings to recommendations. Spine. 2008; 33: S199–S213
  58. Haas, M, Bronfort, G, and Evans, RL. Chiropractic clinical research: progress and recommendations. J Manipulative Physiol Ther. 2006; 29: 695–706
  59. Haas, M, Jacobs, GE, Raphael, R, and Petzing, K. Low back pain outcome measurement assessment in chiropractic teaching clinics: responsiveness and applicability of two functional disability questionnaires. J Manipulative Physiol Ther. 1995; 18: 79–87
  60. Haas, M, Sharma, R, and Stano, M. Cost-effectiveness of medical and chiropractic care for acute and chronic low back pain. J Manipulative Physiol Ther. 2005; 28: 555–563
  61. Haldeman, S, Carroll, L, Cassidy, JD, Schubert, J, and Nygren, A. The Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders: executive summary. Spine (Phila Pa 1976). 2008; 33: S5–S7
  62. in: S Haldeman, D Chapman-Smith, DJ Petersen (Eds.) Guidelines for chiropractic quality assurance and practice parameters. Aspen Publishers, Gaithersburg, MD; 1993
  63. Haldeman, S and Dagenais, S. A supermarket approach to the evidence-informed management of chronic low back pain. Spine J. 2008; 8: 1–7
  64. Fitch, K, Bernstein, SJ, Aquilar, MS et al. The RAND UCLA Appropriateness Method user’s manual.RAND Corp., Santa Monica, CA; 2003
  65. American Medical Association. Guide to the evaluation of permanent impairment. 6th ed. American Medical Association, Chicago; 2008
  66. Schneider, M, Haas, M, Glick, R, Stevans, J, and Landsittel, D. Comparison of spinal manipulation methods and usual medical care for acute and subacute low back pain: a randomized clinical trial.Spine (Phila Pa 1976). 2015; 40: 209–217
  67. National Institute for Health and Care Excellence. Early management of persistent non-specific low back pain. NICE, UK; 2009
  68. van Duijvenbode, I, Jellema, P, van Poppel, MN, and van Tulder, MW. Lumbar supports for prevention and treatment of low back pain. Cochrane Database Syst Rev. 2011; : CD001823
  69. Triano, J, Budgell, B, Bagnulo, A et al. Review of methods used by chiropractors to determine the site for applying manipulation. Chiropr Man Ther. 2013; 21: 36
  70. Carnes, D, Mars, TS, Mullinger, B, Froud, R, and Underwood, M. Adverse events and manual therapy: a systematic review. Man Ther. 2010; 15: 355–363
  71. Dabbs, V and Lauretti, WJ. A risk assessment of cervical manipulation vs. NSAIDs for the treatment of neck pain. J Manipulative Physiol Ther. 1995; 18: 530–536
  72. Boswell, MV, Trescot, AM, Datta, S et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007; 10: 7–111
  73. Deyo, RA, Dworkin, SF, Amtmann, D et al. Report of the NIH task force on research standards for chronic low back pain. Spine (Phila Pa 1976). 2014; 39: 1128–1143
  74. Russell, R. The rationale for primary spine care employing biopsychosocial, stratified and diagnosis-based care-pathways at a chiropractic college public clinic: a literature review. ([Online access only 11 p.])Chiropr Man Ther. 2013; 21
  75. Revicki, D, Hays, RD, Cella, D, and Sloan, J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008; 61: 102–109
  76. Bush, HM, Pagorek, S, Kuperstein, J, Guo, J, Ballert, KN, and Crofford, LJ. The association of chronic back pain and stress urinary incontinence: a cross-sectional study. J Womens Health Phys Ther. 2013;37: 11–18
  77. Bi, X, Zhao, J, Zhao, L et al. Pelvic floor muscle exercise for chronic low back pain. J Int Med Res. 2013; 41: 146–152
  78. Parkin-Smith, GF, Norman, IJ, Briggs, E, Angier, E, Wood, TG, and Brantingham, JW. A structured protocol of evidence-based conservative care compared with usual care for acute nonspecific low back pain: a randomized clinical trial. Arch Phys Med Rehabil. 2012; 93: 11–20
  79. Peterson, CK, Bolton, J, and Humphreys, BK. Predictors of outcome in neck pain patients undergoing chiropractic care: comparison of acute and chronic patients. Chiropr Man Therap. 2012;20: 27
  80. Peterson, CK, Bolton, J, and Humphreys, BK. Predictors of improvement in patients with acute and chronic low back pain undergoing chiropractic treatment. J Manipulative Physiol Ther. 2012; 35: 525–533
Steroid Shots Offer No Long-Term Relief For Low-Back Pain

Steroid Shots Offer No Long-Term Relief For Low-Back Pain

(HealthDay News) � Chronic lower back pain affects millions of Americans. Many try steroid injections to ease their discomfort, but researchers now say this remedy provides only short-term relief.

In their study, investigators from France focused on 135 patients with back pain seemingly caused by inflammation between the discs and bones (vertebrae) in the lower spine.

 

The researchers found that a single steroid injection eased pain for one month. After that, however, effectiveness waned. Virtually no difference was seen one year after treatment between patients who did or didn�t get the injection.

�Our results do not support the wide use of an injection of glucocorticoid in alleviating symptoms in the long term in this condition,� said lead researcher Dr. Christelle Nguyen.

The findings are consistent with earlier studies, said Nguyen, an assistant professor of physical medicine and rehabilitation at Paris Descartes University.

Nguyen said she and her colleagues had hoped that targeting local disc inflammation with an anti-inflammatory steroid would help alleviate long-term pain.

To test their theory, they selected patients with chronic lower back pain and signs of disc inflammation on an MRI. On average, participants had suffered from back pain for six years. Half were assigned to a single steroid shot; the other half got no injection.

Patients rated their pain severity before the injection and again one, three, six and 12 months after the treatment.

One month after treatment, 55 percent of those who got the steroid injection experienced less lower back pain, compared with 33 percent of those who weren�t treated.

�However, the groups did not differ for the assessed outcomes 12 months after the injection,� Nguyen said.

For example, patients who did or didn�t received a steroid injection ended up in similar circumstances, with the same incidence of disc inflammation, lower quality of life, more anxiety and depression and continued use of non-narcotic pain pills, she said.

Overall, most patients found the steroid injections tolerable, and would agree to have a second one if necessary, Nguyen said. �We had no specific safety concerns and found no cases of infection, destruction or calcification of the disc 12 months after the injection,� she added.

The results were published March 20 in the Annals of Internal Medicine.

Dr. Byron Schneider, of Vanderbilt University School of Medicine in Nashville, noted there are many different causes of back pain.

In this study, the patients suffered from chronic back pain, he pointed out. �Patients with chronic lower back [pain] probably have more than one cause of their pain, which may be why the good results they found at one month weren�t there a year later,� said Schneider, an assistant professor of physical medicine and rehabilitation.

The study results don�t mean steroid injections should be avoided altogether, he noted.

Patients with a sudden episode of back pain � so-called acute pain � probably don�t need a steroid injection, he said.

 

Chiropractic Care Boosts Surgery Avoidance

�But if they�re not getting better after a month or two the way we would expect them to, at that point it would be reasonable to discuss the pluses and minuses of a steroid injection,� said Schneider, co-author of an accompanying journal editorial.

Chronic (long-term) back pain is a different situation, he said. Treating chronic back pain means treating the pain itself, but also using cognitive behavior therapy and �pain psychology� to help patients cope with pain, he said.

�For chronic pain, physicians need to address the musculoskeletal reasons that cause the hurt, but also other reasons that patients may be experiencing pain,� Schneider said.

According to the editorial, psychological distress, fear of pain and even low educational levels can affect pain levels.

More information

For more on lower back pain, visit the U.S. National Institute of Neurological Disorders and Stroke.

Chiropractic: Americas Exit Strategy To The Opioid Epidemic

Chiropractic: Americas Exit Strategy To The Opioid Epidemic

The sheer magnitude of America�s prescription opioid abuse epidemic has evoked visceral responses and calls-to-action from public and private sectors. As longtime advocates of drug-free management of acute, subacute and chronic back, neck and neuro-musculoskeletal pain, the chiropractic profession is aligned with these important initiatives and committed to actively participate in solving the prescription opioid addiction crisis.As professionals dedicated to health and well-being, Doctors of Chiropractic (DCs) are educated, trained and positioned�to deliver non-pharmacologic pain management and play a leading role in �America�s Opioid Exit Strategy.�

Data released by the Centers for Disease Control and Prevention (CDC) revealed that opioid deaths continued to surge in 2015, surpassing 30,000 for the first time in recent history. CDC Director Tom Frieden said,�The epidemic of deaths involving opioids continues to worsen. Prescription opioid misuse and use of heroin and illicitly manufactured fentanyl are intertwined and deeply troubling problems.�1

The human toll of prescription opioid use, abuse, dependence, overdose and poisoning have rightfully become a national public health concern. Along with the tragic loss of life, it is also creating a monumental burden on our health and related health care costs:

  • Health care costs for opioid abusers are eight times higher than for nonabusers.2
  • A new retrospective cohort study shows a 72 percent increase in hospitalizations related to opioid abuse/dependence from 2002 to 2012. Not surprisingly, inpatient charges more than quadrupled over that time. Previous estimates of the annual excess costs of opioid abuse
    to payers range from approximately $10,000 to $20,000 per patient, imposing a substantial economic burden on payers.3
  • A recent government study puts the economic burden to the U.S. economy at $78.5 billion annually. For this study, CDC researchers analyzed the financial impact to include direct health care costs, lost productivity and costs to the criminal justice system.4

AMERICA�S COMMITMENT TO PRESCRIPTION OPIOID ABUSE: A PAINFUL REALITY CHECK

As a non-pharmacologic approach to effectively address acute, subacute and chronic non- cancer pain, integrative care management answers the needs of individuals nationwide.

With patient access to opioids becoming more restricted through more responsible clinician prescribing and government-mandated reduced production of opioids — and as those who are addicted become empowered to reduce their utilization — people experiencing pain face new, daunting challenges:

  • Without the use of drugs, how will they cope with pain?
  • How can they get referrals and access to drug-free care that will be effective for acute, subacute and chronic pain?
  • How can they ensure that their health care plans and insurance will cover the cost of non- pharmacologic care?

While the chiropractic profession lauds many of the noteworthy announcements and strides to overcome opioid addiction, these recommendations fall short in providing meaningful answers and solutions for those who are suffering from pain.

It is encouraging to see the July 22, 2016 enactment of the Comprehensive Addiction and Recovery Act (P.L. 114-198), the first major federal addiction legislation in 40 years, and the most comprehensive effort undertaken to address the opioid epidemic. It encompasses
all six pillars necessary for such a coordinated response � prevention, treatment, recovery, law enforcement, criminal justice reform and overdose reversal.5 The recent passage of the 21st Century Cures Act included $1 billion for states to use to fight opioid abuse.6 Unfortunately, this legislation has drawn critics who say it is simply a huge de-regulatory giveaway to the pharmaceutical and medical device industry.7

Closer examination of these legislative initiatives points to the absence of programs that address non-pharmacologic options for those fighting drug addiction, notably chiropractic care. When paired with the U.S. Surgeon General�s declaration of war on addiction,8 the government�s designation of �Prescription Opioid and Heroin Epidemic Awareness Week,� 9 and the commitment from 40 prescriber groups to ensure that 540,000 health care providers would complete training on appropriate opioid prescribing within two years,10 these �solutions� appear woefully inadequate to address the challenges of those who need effective, drug- free pain management.

This follow-up discussion to �Chiropractic: A Safer Strategy than Opioids� (June 2016), examines the positive steps as well as the shortcomings of initiatives undertaken from July 2016 – March 2017 to address the opioid crisis. It also assesses the current landscape of opportunities to offer patients, doctors and payers meaningful programs to effectively address acute, subacute and chronic neck, low back and neuro-musculoskeletal pain without the use of painkillers.

The chiropractic profession contends this should be a top priority, and it appears that a growing number of stakeholders are in agreement. In fact, the world�s second-largest pharmaceutical company has agreed to disclose in its marketing material that opioid painkillers might carry a serious risk of addiction, and promised not to promote prescription opioids for unapproved uses, such as long-term back pain.11

Based upon the evidence articulated in this document, it becomes clear that chiropractic care is a key component of �America�s Opioid Exit Strategy� on several levels:

  • �Perform first-line assessment and care for neck, back and neuro-musculoskeletal pain to avoid opiate prescribing from the first onset of pain.
  • �Provide care throughout treatment to mitigate the introduction of drugs.
  • �Offer an effective approach to acute, subacute and chronic pain management that helps addicts achieve a wellness focused, pain-free lifestyle as they reduce their utilization of opioids.

It�s also a compelling opportunity for our health system, commercial and government payers, employers — and most importantly patients — to resolve the issues surrounding pain at lower costs, with improved outcomes and without drugs or surgery.

Further complicating the situation: escalating prices of the opioid OD drug naloxone may threaten efforts to reduce opioid-related deaths across America, warn teams at
Yale University and the Mayo Clinic.13

Naloxone is a drug given to people who overdose on prescription opioids and heroin. If administered in time, it can reverse the toxic and potentially deadly effects of �opioid intoxication.�

The research team called attention to skyrocketing prices for the lifesaving antidote, noting:

  • Hospira (a Pfizer Inc. company) charges $142 for a 10-pack of naloxone — up 129 percent since 2012.
  • Amphastar�s 1 milligram version of naloxone is used off-label as a nasal spray. It�s priced around $40 — a 95 percent increase since September 2014.
  • Newer,easier-to-use formulations are even more expensive — a two-dose package of Evzio (naloxone) costs $4,500, an increase of more than 500 percent over two years.�The challenge is as the
    price goes up for naloxone, it becomes less accessible for patients,� said Ravi Gupta, the study�s lead author.

Government & Regulators Restrict Access To Opioids

In the wake of this firestorm surrounding opioid abuse, and following the dissemination of prescribing guidelines introduced by the CDC, it becomes evident that certain market forces are influencing the battle against opioid addiction and the availability of drugs.

Among the most egregious stakeholders are those in the pharmaceutical sector.There are numerous instances which document their role attempting to thwart many legislative initiatives throughout the country to combat drug abuse.They impose exorbitant costs for life-saving antidotes, and aggressively develop and market the use of more drugs to fight opioid-induced side effects such as constipation. It becomes apparent that many of their answers to opioid addiction are simply more pills.14

The opioid market is worth nearly $10 billion in annual sales, and has expanded to include an unlimited universe of medications aimed at treating secondary effects rather than controlling pain.15 Given the financial incentives to produce, sell and distribute drugs, it�s no wonder that pharmaceutical companies (pharmcos) have a material interest in promoting drug utilization.

This set of behaviors has drawn extensive criticism.

�The root cause of our opiate epidemic has been the over-prescribing of prescription pain medications. Physicians get little to no training related to addiction in general, but particularly around opiate prescriptions. Over the past year, however, you hear more and more physicians admitting �we are part of the problem and can be part of the solution�.�16

—- Michael Botticelli, former White House drug policy director, commonly called the nation�s drug czar.

While physicians have been responding to calls for more responsible prescribing, the drug industry has historically been accused of providing physicians with misleading information regarding the addictive qualities of certain drugs.Appropriate education of prescribers is a key component of necessary change.

For example, when semisynthetic opioids like oxycodone and hydrocodone � found in Percocet and Vicodin respectively � were first approved in the mid�20th century, they were recommended only for managing pain during terminal illnesses such as cancer, or for acute short-term pain, like recovery from surgery, to ensure patients wouldn�t get addicted. But in the 1990s, doctors came under increasing pressure to use opioids to treat the millions of Americans suffering from chronic non-malignant conditions, like back pain and osteoarthritis.

A physician pain specialist helped lead the campaign, claiming prescription opioids were a �gift from nature,� with assurances to his fellow doctors � based on a 1986 study of only 38 patients � that fewer than one percent of long-term users became addicted.17

Today, drug makers may be getting their �wings clipped� with the introduction of new government directives slashing production of popular prescription painkillers. In 2016, the U.S. Drug Enforcement Administration (DEA) finalized a previous order on 2017 production quotas for a variety of Schedule I and II drugs, including addictive narcotics like oxycodone, hydromorphone, codeine and fentanyl. The agency has the authority to set limits on manufacturing under the Controlled Substances Act. The DEA said it is reducing �the amount of almost every Schedule II opiate and opioid medication� by at least 25 percent.18 Some, like hydrocodone, commonly known by brand names like Vicodin or Lortab, will be cut by one-third.

Despite these setbacks, the drug industry continues to launch strong initiatives that fight state- mandated opioid limits. Amid the crisis and regardless of the pressures urging a shift away from opioid use, the makers of prescription painkillers recently adopted a 50-state strategy that includes hundreds of lobbyists and millions in campaign contributions to help kill or weaken measures aimed at stemming the tide of prescription opioids.19

While the drug makers vow they�re combating the addiction problem,The Associated Press
and the Center for Public Integrity found that these manufacturers often employ a statehouse playbook of delay and defend tactics.This includes funding advocacy groups that use the veneer of independence to fight limits on the drugs, such as OxyContin, Vicodin and Fentanyl, a potent, synthetic opioid pain medication with a rapid onset and short duration of action that is estimated to be between 50 and 100 times as potent as morphine.20

In its national update released Dec. 16, 2016 in the Morbidity and Mortality Weekly Report, the CDC reported that more than 300,000 Americans have lost their lives to an opioid overdose since 2000.

As enforcement restricts the availability of prescription opioids, people addicted
to painkillers — such as oxycodone (OxyContin) and morphine — have increasingly turned to — street drugs like heroin.21

These independent sources also found that the drug makers and allied advocacy groups employed an annual average of 1,350 lobbyists in legislative hubs from 2006 through 2015, when opioids� addictive nature came under increasing scrutiny.

�The opioid lobby has been doing everything it can to preserve the status quo of aggressive prescribing.They are reaping enormous profits from aggressive prescribing.�22

Andrew Kolodny, MD, founder, Physicians for Responsible Opioid Prescribing

Undaunted by these interferences, and buoyed by a thirst for profits, pharmcos are now fueling other creative solutions to drive even greater revenues from the sale and distribution of drugs.

It now appears that pharmcos are directing their activities toward medicines known as abuse-deterrent formulations: opioids with physical and/or chemical barriers have built-in properties that make the pills difficult to crush,chew or dissolve.This aims to deter abuse through intranasal and intravenous routes of administration.These drugs ultimately are more lucrative, since they�re protected by patent and do not yet have generic competitors.They cost insurers more than generic opioids without the tamper-resistant technology.23

Skeptics warn that they carry the same risks of addiction as other opioid versions, and the U.S. FDA noted that they don�t prevent the most common form of abuse � swallowing pills whole.

�This is a way that the pharmaceutical industry can evade responsibility, get new patents and continue to pump pills into the system,� said Dr. Anna Lembke, Chief of Addiction Medicine at the Stanford University School of Medicine.24

Drug makers have discovered yet another way to profit from addicts taking high doses of prescription opioid painkillers � the new billion-dollar drug to treat opioid-induced constipation (OIC) rather than controlling pain.

Studies show that constipation afflicts 40-90 percent of opioid patients.Traditionally,doctors advised people to cut down the dosage of their pain meds, take them less often or try non-drug interventions. By promoting OIC as a condition in need of more targeted treatment, the drug industry is creating incentives to maintain painkillers at full strength and add another pill instead.25

Collectively, the subsets of new pharmaceutical submarkets to treat opioid addiction, overdoses, and side effects such as OIC are estimated to be worth at least $1 billion a year in sales.These economics, some experts say, work against efforts to end the epidemic.26

While there is continued pressure to limit the number and scope of opiates for patients, new government statistics reveal that drug overdose deaths continue to surge in the United States, now exceeding the number of deaths caused by motor vehicle accidents.27 Although it is reported that the number of opioid prescriptions has fallen across the U.S. over the past three years, with intermittent data on this decline in states such as West Virginia and Ohio, they still kill more Americans each year than any other drug.

Just over 33,000 (63 percent) of the more than 52,000 fatalities reported in 2015 are linked to the illicit use of prescription painkillers.28 States including Massachusetts, and most recently Virginia, have declared public health emergencies as the number of deaths has escalated.29

Regardless of whether these issues are viewed from the perspective of patients, clinician prescribers, or government regulators, the status quo is clearly not acceptable.

Responsible Prescribing

�My new patient didn�t mention his back pain until the very end of the visit.As he was rising to leave, he asked casually if I could refill his Percocet. I told him I am not a pain or a back specialist and that I generally prescribe muscle relaxants or anti-inflammatory medications for back pain � not opioids, which are addictive and do not really treat the underlying problem.

The patient persisted. He said his prior internist always prescribed it, and the medication also helped his mood. He promised he had its use under control and did not feel he needed to take more and more to achieve the same effect.

I didn�t relent. I offered to refer him to a back specialist instead. It was an uncomfortable end to an otherwise positive visit.

Unfortunately, we doctors are enablers.Too many of us fill those prescriptions for chronic pain. And when we don�t, too many of our patients leave us for other doctors who will. Or worse, they turn to buying heroin on the street.�30

Marc Siegel, MD, FOX NEWS

Clinical prescribers of pain medications are beginning to recognize their responsibilities for increased prescribing vigilance, and are expected to become important advocates for drug-free pain care. More than half of doctors across America are curtailing opioid prescriptions, and nearly 1 in 10 have stopped prescribing the drugs, according to a new nationwide online survey. More than one-third of the respondents said the reduction in prescribing has hurt patients with chronic pain.

The survey, conducted for The Boston Globe by the SERMO physicians social network, offers fresh evidence of the changes in prescribing practices in response to the opioid crisis that has killed thousands in New England and elsewhere around the country.The deaths awakened fears of addiction and accidental overdose, and led to state and federal regulations aimed at reining in excessive prescribing.

Doctors face myriad pressures as they struggle to treat addiction and chronic pain, two complex conditions in which most physicians receive little training.Those responding to the survey gave two main reasons for cutting back: the risks and hassles involved in prescribing opioids, and a better understanding of the drugs� hazards.31

In Wisconsin, the Medical Society says the state�s effort to fight the opioid epidemic is showing results.A new report found about eight million fewer opioids were dispensed between July and September 2016 compared to the same time during the previous year.The Medical Society says it�s doing more to help physicians monitor patients� use of opioids by supporting the release of an enhanced prescription drug monitoring program � or PDMP. Starting in April 2017, doctors will have to access the program while pharmacists will only have 24 hours to enter information instead of seven days.This gives doctors an update in case patients are going from doctor to doctor for more prescriptions.32

Prescription drug monitoring programs (PDMPs), launched in 2013, are state-run electronic databases used to track the prescribing and dispensing of controlled prescription drugs to patients.They are designed to monitor this information for suspected abuse or diversion (i.e., channeling drugs into illegal use), and can give a prescriber or pharmacist critical information regarding a patient�s controlled substance prescription history.This information can help prescribers and pharmacists identify patients at high-risk who would benefit from early interventions.

PDMPs continue to be among the most promising state-level interventions to improve opioid prescribing, inform clinical practice and protect patients at risk.33

Hospital Admissions Due To Heroin, Painkillers Rose 64% 2005-2014

Researchers found misuse of prescription painkillers and street opioids climbed nationwide, related hospital stays jumped from 137 per 100,000 people to 225 per 100,000 in that decade.

States where overdoses required at least 70 percent more hospital beds between 2009 and 2014 were North Carolina, Oregon, South Dakota and Washington.

In 2014, the District of Columbia, Maryland, Massachusetts, New York, Rhode Island and West Virginia each reported rates above 300 per 100,000 people — far above the national average.34

Health Plans Report Limited Prescribing Is Paying Off

According to IMS Health, a global health information and technology firm, the rate of opioid prescribing in the U.S. has dropped since its peak in 2012.The drop is the first that has been reported since the early 1990s, when OxyContin first hit the market and pain became �the fifth vital sign� doctors were encouraged to more aggressively treat.35

However, continued pressure on physician prescribing patterns and opportunities for therapies other than opioids may be paying off. Prescriptions for powerful painkillers dropped significantly among patients covered by Massachusetts� largest insurer after measures were introduced to reduce opioid use.36 The Blue Cross Blue Shield of Massachusetts program serves as an example of a private health insurer collaborating on a public health goal.

In 2012, the insurer � the state�s largest, with 2.8 million members � instituted a program intended to induce doctors and patients to weigh the risks of opioids and consider alternatives.As part of that initiative, first-time opioid prescriptions are limited to 15 days, with a refill allowed for 15 more days. Blue Cross must approve in advance any prescription for longer than a month or for any long-acting opioid such as OxyContin. Pharmacy mail orders for opioids are prohibited.

Doctors and others who prescribe must assess the patient�s risk of abusing drugs and develop a treatment plan that considers options other than opioids. And patients with chronic pain are referred to case managers who advise on therapies other than opioids.

By the end of 2015, the average monthly prescribing rate for opioids decreased almost 15 percent, from 34 per 1,000 members to 29. About 21 million fewer opioid doses were dispensed during the three years covered in the study.37

In another example, Highmark (Pennsylvania) shared data in December 2016 showing that the number of prescriptions for opioids it reimbursed in each of the past three months was lower than in any of the prior nine months. One leading health plan in the state reported that 16 percent of its insured population received at least one opioid prescription in 2016, down from 20 percent in 2015.38 UPMC Health Plan indicated it is using �an algorithm to identify patients who may be at risk for opioid addiction,� and training doctors to use other pain management tools.

Mounting Evidence & Support For Non-Pharmacologic Care For Acute, Subacute & Chronic Back, Neck & Neuro-Musculoskeletal Pain

The earlier sections of this white paper have focused on the continuing and growing problem of opioid use, abuse and addiction. It is essential that this information is understood and appreciated as it clearly calls for a wholesale change in the approach American health care providers and patients bring to the care and management of pain.

No matter what is done to address the use, abuse and addiction associated with opioids it is a fact of life that opioid containing products will continue to be required by individuals suffering severe, intractable and unrelenting pain.This issue is not about the cessation of all opioid use, rather it is about not turning to opioids before they are required, and not until all less onerous approaches to pain management have been exhausted.

We began this discussion with three questions in mind:

  • �Without the use of drugs, how will they cope with pain?
  • How can they get referrals and access to drug-free care that will be effective for both acute, subacute and chronic pain?
  • �How can they ensure that their health care plans and insurance will cover the cost of non- pharmacologic care?

According to new guidelines developed by the American College of Physicians,39 conservative non-drug treatments should be favored over drugs for most back pain. The guidelines are an update that include a review of more than 150 recent studies and conclude that,�For acute and subacute pain, the guidelines recommend non-drug therapies first, such as applying heat, massage, acupuncture, or spinal manipulation, which is often done by a chiropractor.�

The Wall Street Journal

As we have previously noted the CDC, FDA and IOM have all called for the early use of non- pharmacologic approaches to pain and pain management. Unfortunately, beyond asserting the need to move in this direction, little, if any, guidance has been offered to providers, patients and payors on how to accomplish this important transition.

It is a fact that a chasm exists between the worlds of pharmacologic based management of pain, and the non-pharmacologic based management of pain. Medical physicians are not going to suddenly attain knowledge and understanding of practices, procedures and management options that they have never been trained in or exposed to. Similarly, the non-pharmacologic providers addressing pain management do not encounter or understand the barriers that prevent prescribers from directing patients toward non-pharma approaches.These two spheres of healthcare are distinct and separate, and demonstrate little, if any, knowledge about the other.

The first step is to provide resources to prescribers that will detail the indications, effectiveness, efficiency and safety of non-pharmacologic approaches. In particular, the chiropractic profession, through its 70,000 practitioners in the United States, represents a significant and proven non- pharmacologic approach for reducing the need for opioids, opioid-related products and non- opioid pain medications.

Chiropractic, like other complementary health care approaches, suffers from a lack of awareness about its high level of education, credentialing and regulation. In addition, a substantial awareness gap exists among frontline providers in terms of referring patients to chiropractors as part of patient care.

The chiropractic profession and the health care consumer are equally supported by a robust oversight infrastructure.This infrastructure ranges from institutional and programmatic accreditation of chiropractic education by agencies recognized by the U.S. Department of Education to standardize national credentialing examinations and licensure by state agencies and ongoing professional development as a requirement for continued practice in many states.

Typically, after earning a Bachelor of Science, chiropractors follow a four-year curriculum to earn a Doctor of Chiropractic (DC) as a prerequisite to earning the right to independent practice. Chiropractic, medical, osteopathic, dental, optometric and naturopathic education share a similar foundation in the basic sciences, followed by discipline-specific content that focuses on the unique contribution of each provider type. For example, a medical student pursues the study of pharmacology and surgery, while a chiropractic student studies the intricacies of manual approaches to health care and the acquisition of the skills needed to perform spinal adjusting or manipulation.

Chiropractors also pursue specialization in specific areas, such as radiology, through structured residency programs, similar to other disciplines. DCs also pursue focus areas related to various methods of spinal adjusting and related patient management.

For over a century, DCs have studied the relationship between structure, primarily the spine, and function, primarily of the nervous system, and how this interrelationship impacts health and well- being. Due to this emphasis on the spine, chiropractors have become associated with spinal and skeletal pain syndromes, and bring their non-surgical, non-drug rationale to the management of these problems.

DCs are the quintessential example of non-pharmacologic providers of health care with particular expertise in neuro-musculoskeletal conditions.

A Look At The Evidence

While the United States is attempting to deal with its opioid epidemic, our nation is making only limited headway in providing non-pharmacologic approaches to patients with pain.

Over 100 million Americans suffer with chronic pain,40 and an estimated 75 to 85 percent of all Americans will experience some form of back pain during their lifetime. However, 50 percent of
all patients who suffer from an episode of low back pain will have a recurrent episode within one year.41 Surgery has a very limited role in the management of spinal pain, and is only considered appropriate in a handful of cases per hundred patients. Likewise, opioids have very limited utility in the spinal pain environment with the recommended use of these drugs being limited to three days.

Of special relevance, this data relates to the most commonly-reported pain conditions:42

  • When asked about four common types of pain, respondents of a National Institute of Health Statistics survey indicated that low back pain was the most common (27 percent), followed by severe headache or migraine pain (15 percent), neck pain (15 percent) and facial ache or pain (4 percent).
  • Back pain is the leading cause of disability in Americans under 45 years old. More than 26 million Americans between the ages of 20-64 experience frequent back pain.
  • Adults with low back pain are often in worse physical and mental health than people who do not have low back pain: 28 percent of adults with low back pain report limited activity due to a chronic condition, as compared to 10 percent of adults who do not have low back pain. Also, adults reporting low back pain were three times as likely to be in fair or poor health and more than four times as likely to experience serious psychological distress as people without low back pain.

Results of a 2010 study indicate that DCs provide approximately 94 percent of the manipulation services performed in the U.S.,43 with a number of published studies documenting manipulation, along with other drug-free interventions, as effective for the management of neck44 and back pain.45 Most high-quality guidelines target the noninvasive management of nonspecific low back pain and recommend education, staying active/exercising, manual therapy, and paracetamol or NSAIDs as first-line treatments.46

Action Needed

Care pathways and clinical guidelines need to be modified to bring greater attention to the use of non-pharmacologic approaches to pain management. Primary medical care providers must be encouraged to make recommendations or referrals to drug-free resources and appropriate providers, such as DCs, rather than turning to the prescription pad when managing patients who have pain, particularly those with spinal pain. Patients should be educated about non- pharmacologic options for dealing with pain first and foremost, and the dangers of opioids.

For these good intentions to be effective, drug-free pathways will need to be funded by payers in the private sector and government. Government leadership and policy support for introducing innovative reimbursement initiatives by the CMS is a critical step toward allowing health providers to acquire familiarity with non-pharmaceutical approaches.These could frame and stimulate use of evidence-based care options and promote referrals, access to care and reimbursement. By re- engineering these approaches to care to fit the current health care landscape, rather than simply reacting to the opioid crisis by de-emphasizing pain treatment, CMS can better serve patients.

One example: CMS should consider a chronic pain shared-savings program targeting accountable care organizations (ACOs), where success is tied explicitly to patient functional outcomes. Benchmarking against ACO performance measures to determine if care results in savings or losses would allow these organizations to work towards meeting or exceeding quality performance standards � leading to receiving a portion of the savings generated. By incorporating incentives, this type of model would be consistent for more effective integrative intervention for pain.47

Fortunately, progressive thinking is gaining traction in this area. In a January 5, 2017 posting on the CMS Blog, authors wrote that the CMS is focusing on significant programs, including increased use of evidence-based practices for acute and chronic pain management.

�We are working with Medicare and Medicaid beneficiaries, their families and caregivers, health care providers, health insurance plans and states to improve how opioids are prescribed by providers and used by beneficiaries, how opioid use disorder is identified and managed, and how alternative approaches to pain management can be promoted.�48

While we applaud CMS, we feel it is important to point out that this approach begins with a focus on how opioids are prescribed.The focus needs to shift to early applications of non-pharmacologic approaches first and not as a follow-on after the drug path has been established.

Documented Results & Cost Savings

WORKPLACE INJURIES

Back pain is the most common occupational injury in the United States and Canada,49 and represents the most common non-fatal occupational injury, according to the U.S. Bureau of Labor Statistics. Musculoskeletal disorders (MSDs), such as sprains or strains resulting from overexertion in lifting, accounted for 31 percent (356,910 cases) of the total cases for all workers.50

Most recently, Maine Department of Labor data showed injuries to a person�s lumbar region represented 14.3 percent of all injuries reported in 2014, up from 10.7 percent just five years earlier.51 Health care employees have among the highest rates of musculoskeletal injuries for workers, second only to those working in the transportation and warehousing sectors.52

Opiates are not a safe alternative especially when operating heavy machinery, transportation or caring for patients because side effects can alter performance and have tragic outcomes.

Take for example, a 56-year-old nurse at the Maine Medical Center in Portland. She relies on a comprehensive strategy to address her chronic back pain, which originates from having to wear heavy lead aprons when giving radiation treatments, and moving patients and equipment. Her regimen, which includes regularly seeing a chiropractor, exercises, stretches and building up her core muscles, has helped her to control her pain.53

In terms of the value of a �gatekeeper� health care provider for insured workers like this nurse, a study published in Journal of Occupation Rehabilitation (September 17, 2016) cites this factor as
a significant predictor of the duration of the first episode of a worker�s compensation claim. They analyzed a cohort of 5,511 workers, comparing the duration of financial compensation and the occurrence of a second episode of compensation for back pain among patients seen by three types of first health care providers: physicians, chiropractors and physical therapists in the context of workers� compensation.54

When compared with medical doctors, chiropractors were associated with shorter duration of compensation and physical therapists (PT) with longer ones.There was also greater likelihood that PT patients were more likely to seek additional types of care that incurred longer compensation duration.

Additionally, earlier research confirms that on a case adjusted basis 42.7 percent of workers who initially visited a surgeon underwent surgery compared with only 1.5 percent of those who first consulted a chiropractor.55

Medicaid

The National Academy for State Health Policy (NASHP), an independent academy of state health policymakers dedicated to helping states achieve excellence in health policy and practice, recently studied chronic pain management therapies in Medicaid, including policy considerations for non-pharmacological alternatives to opioids. A non-profit and non-partisan organization, NASHP provides a forum for constructive work across branches and agencies of state government on critical health issues.56

SURVEY RESULTS:

�Has your Medicaid agency implemented specific policies or programs to encourage or require alternative pain management strategies in lieu of opioids for acute or chronic non-cancer pain?�

A September 2016 NASHP report states that although most Medicaid agencies cover services that can be used as alternatives to opioids for pain management, significantly fewer states have policies or procedures in place to encourage their use.

Between March and June 2016, NASHP conducted a survey of all 51 Medicaid agencies to determine the extent to which states have implemented specific programs or policies to encourage or require non-opioid therapies for acute or chronic non-cancer pain.They contacted each Medicaid director via email and, in cases of non-response, followed up with Medicaid medical directors. Ultimately, they received responses from 41 states and the District of Columbia.

Because reimbursement is a key incentive to access alternative care, they also note the most recent results of Medicaid agency reimbursement data from The Henry J. Kaiser Family Foundation (KFF):57

� 27 reimbursed chiropractic services;
� 36 reimbursed occupational therapy services;

� 38 reimbursed psychologist services;
� 39 reimbursed physical therapy services.

Among the key findings, researchers found most Medicaid agencies cover services that can be used to treat pain in lieu of opioids, but less than half have taken steps to specifically encourage or require their use. Non-pharmacological therapies commonly used to address pain include physical therapy, cognitive behavioral therapy, and exercise, as well as other services, commonly known as Complementary and Alternative Medicine (CAM), including chiropractic manipulation, acupuncture and massage.

They point out that while the current literature on non-pharmacological alternatives is mixed, there is a growing body of evidence to support the use of alternative services to treat chronic pain. For example, a systematic review suggests lower costs for patients experiencing spine pain who received chiropractic care.58

This finding is substantiated in Rhode Island, where the state�s Section 1115 Demonstration authorizes certain individuals enrolled in Medicaid managed care delivery systems to receive CAM services for chronic pain.59 Rhode Island Medicaid has implemented this benefit through its Communities of Care program, a state initiative designed to reduce unnecessary emergency room utilization. Medicaid managed care enrollees with four or more emergency room visits within a 12-month period are eligible to receive acupuncture, chiropractic or massage therapy services.

The state�s two managed care plans, Neighborhood Health Plan of Rhode Island (NHPRI) and United HealthCare of New England, were responsible for developing participation criteria for their enrollees. For example, NPRHI published clinical practice guidelines for its Ease the Pain program, which specified when CAM services referrals were appropriate. Under NHPRI�s guidelines, qualifying individuals diagnosed with back pain, neck pain, and fibromyalgia can be referred for chiropractic services, acupuncture and massage.

Substantiating the results for CAM, Advanced Medicine Integration Group, L.P. in Rhode Island contracted with the two health plans to identify and manage their Medicaid eligible members suffering from chronic pain through its Integrated Chronic Pain Program (ICPP).The target Medicaid population for this program was the Community of Care (CoC) segment — high utilizers of ER visits and opioids/pharmaceuticals.

The objectives of the ICPP are to reduce pain levels (and opioid use), improve function and overall health outcomes, reduce emergency room costs and, through a holistic approach and behavioral change models, educate members in self-care and accountability.

The design of the program for this patient population features holistic nurse case management with directed use of patient education, community services and CAM modalities, including chiropractic care, acupuncture and massage.

Individuals with chronic pain conditions were identified using proprietary predictive modeling algorithms applied to paid claims data to determine opportunities for reducing chronic pain-related utilization and costs.

Results for enrolled CoC Medicaid members with chronic pain conditions document:

  • �Reduced per member per year (PMPY) total average medical costs by 27 percent
  • �Decreased the average number of ER visits by 61 percent
  • Lowered the number of average total prescriptions by 63 percent
  • �Reduced the average number of opioid scripts by 86 percent

These reductions exceeded by two to three times those reported for a non-enrolled control group of conventionally managed CoC chronic pain patients. Every $1 spent on CAM services and program fees resulted in $2.41 of medical expense savings.

Military

At the time of publication, a study entitled: Assessment of Chiropractic Treatment for Low Back Pain and Smoking Cessation in Military Active Duty Personnel, has completed its clinical trial activities and is currently in the analysis phase. Funded by a four-year grant from the Department of Defense, it is the largest multi-site clinical trial on chiropractic to date, with a total sample size of 750 active- duty military personnel.60

The purpose of this study is to evaluate the effectiveness of chiropractic manipulative therapy for pain management and improved function in active duty service members with low back pain that do not require surgery.The study also measures the impact of a tobacco cessation program delivered to participants allocated to the chiropractic arm.

Low back pain (LBP) is the most common cause of disability worldwide, but it is even more prevalent in active duty military personnel. More than 50 percent of all diagnoses resulting in disability discharges from the military across all branches are due to musculoskeletal conditions. LBP has been characterized as �The Silent Military Threat� because of its negative impact on mission readiness and the degree to which it compromises a fit fighting force. For these reasons, military personnel with LBP need a practical and effective treatment that relieves their pain and allows them to return to duty quickly. It must preserve function and military readiness, address the underlying causes of the episode and protect against re-injury.

This multisite Phase II Clinical Comparative Effectiveness Trial is designed to rigorously compare the outcomes of chiropractic manipulative therapy (CMT) and conventional medical care (CMC) to CMC alone. Chiropractic treatment will include CMT plus ancillary physiotherapeutic interventions. CMC will be delivered following current standards of medical practice at each site. At each of the four participating sites, active military personnel, ages 18 to 50, who present with acute, sub-acute or chronic LBP that does not require surgery will be randomized to one of the two treatment groups.

Outcome measures include the Numerical Rating Scale for pain, the Roland-Morris Low Back Pain and Disability questionnaire, the Back Pain Functional Scale for assessing function, and the Global Improvement questionnaire for patient perception regarding improvement in function. Patient Expectation and Patient Satisfaction questionnaires will be used to examine volunteer expectations toward care and perceptions of that care. Pharmaceutical use and duty status data will also be collected.The Patient Reported Outcomes Measurement Information System (PROMIS-29) will be utilized to compare the general health component and quality of life of the sample at baseline.

Also, because DCs are well positioned to provide information to support tobacco cessation, this clinical trial includes a nested study designed to measure the impact of a tobacco cessation program delivered by a DC.The results will provide critical information regarding the health and mission-support benefits of chiropractic health care delivery for active duty service members in the military.61

This current research was preceded by a pilot study on LBP, conducted at an Army Medical Center in El Paso,Texas, with 91 active-duty military personnel between the ages of 18 and
35.62 Results reported in the journal SPINE showed that 73 percent of those who received standard medical care and chiropractic care rated their improvement as pain �completely gone,��much better� or �moderately better.� In comparison, 17 percent of participants who received only standard medical care rated their improvement this way.These results, as well as other measures of pain and function between the two groups, are considered both clinically and statistically significant.

Recommendations & Next Steps

The opioid crisis has provided a wake-up call for regulators, policy experts, clinicians and payers nationwide. As the support for complementary health techniques builds, interdisciplinary and integrative approaches to chronic pain management are considered best practices.

While the Centers for Disease Control and Prevention�s Guideline validates the need for a shift away from the utilization of opioid prescription painkillers as a frontline treatment option for pain relief, the mention of chiropractic care as a safe, effective and drug-free alternative is omitted.

Instead, CDC recommendations encourage utilization of physical therapy, exercise and over- the-counter (OTC) pain medications prior to prescription opioids for chronic pain.63

�Though the guidelines are voluntary, they could be widely adopted by hospitals, insurers and state and federal health systems.�

CBS News64

The CDC rarely advises physicians on how to prescribe medication — which further adds to the significance of their pronouncements. Many payers and state legislators have already added these findings to their coverage on the use of opioids.

With the likelihood of major players in the industry adopting the well-respected guidelines, it is critical that chiropractic care receives the consideration it deserves.

Chiropractic care has earned a leading role as a pain relief option and is regarded as an important element of the nation�s Opioid Exit Strategy: a drug-free, non-invasive and cost-effective alternative for acute or chronic neck, back and musculoskeletal pain management.

For individuals who may be suddenly �cut-off� from painkillers, chiropractic offers a solution. But access to care will depend upon several important factors:

  • �Pharmaceutical Industry �Re-engineering�: A change toward responsible marketing and physician education.
  • �Physician Referrals to Ensure Access to Chiropractic Care: Physician prescribing of chiropractic care rather than opioids.
  • �Benefit Coverage and Reimbursement for Chiropractic Care: Government and commercial payers as well as plan sponsors have a responsibility to offer patients the option of chiropractic care � and reimburse DCs as participating providers.
  • �Access to Chiropractic Care for Active Military and Veteran Populations: Chiropractic care should be expanded in the Department of Defense and veterans� health care systems.

As a nation, we have all come to recognize that pain is a complex, multifaceted condition that impacts millions of Americans, their families and caregivers. Unfortunately, the lessons learned about long-term opioid therapy for non-cancer pain have been deadly and heartbreaking.We now understand that there is little to no evidence to support their effectiveness for ongoing chronic pain management.

It is now incumbent upon all stakeholders to increasingly explore the appropriateness, efficacy and cost-effectiveness of alternative pain management therapies and embrace these solutions as a realistic opportunity for America�s Opioid Exit Strategy.

End Notes

1 Ingraham, Christopher; Heroin deaths surpass gun homicides for the first time, CDC data shows. Washington Post, December
8, 2016. www.washingtonpost.com/news/wonk/wp/2016/12/08/heroin-deaths-surpass-gun-homicides-for-thefirst-time-cdc-data-show/?utm_term=.38c3d6096d4d;
accessed December 8, 2016.
2 Ronan, M. V., & Herzig, S. J. (2016). Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections
Increased Sharply, 2002�12. Health Affairs, 35(5), 832-837. doi:10.1377/hlthaff.2015.1424.
3 J Manag Care Spec Pharm. [Published online January 3, 2017].Academy of Managed Care Pharmacy.
www.jmcp.org/doi/pdf/10.18553/jmcp.2017.16265.
4 Dallas, Mary Elizabeth; Opoid Epidemic Costs U.S. $78.5 Billion Annually; HealthDay, September 21, 2016.
consumer.healthday.com/bone-and-joint-information-4/opioids-990/opioid-epidemic-costs-u-s-78-5-billion-annually-cdc-714931.html.
5 Comprehensive Addiction and Recovery Act (CARA);
www.cadca.org/comprehensive-addiction-and-recovery-act-cara.
6 DeBonis, Mike; 21st Century Cures Act, boosting research and easing drug approvals; Washington Post, December 8, 2016;
www.washingtonpost.com/news/powerpost/wp/2016/12/07/congress-passes-21st-century-cures-act-boostingresearch-and-easing-drug-approvals/?utm_term=.53351c0273f5&wpisrc=nl_sb_smartbrief
7 Hiltzik, Michael; The 21st Century Cures Act; LA Times, January 5, 2017. www.latimes.com/business/hiltzik/la-fi-hiltzik-
21st-century-20161205-story.html
8 U.S. Surgeon General Declares War on Addiction; Medline Plus, November 17, 2016;
medlineplus.gov/news/fullstory_162081.html; accessed December 7, 2016.
9 Obama Administration announces Prescription Opioid and Heroin Epidemic Awareness Week; Proclamation by
President Obama, September 16, 2016. www.whitehouse.gov/the-press-office/2016/09/19/fact-sheet-obama-administration-announces-prescription-opioid-and-heroin
10 Obama Administration announces Prescription Opioid and Heroin Epidemic Awareness Week, 2016
11 Shedrofsky, Karma; Drug czar: Doctors, drugmakers share blame for opioid epidemic; USA Today, July 7, 2016; http://
www.usatoday.com/story/news/2016/07/06/drug-czar-doctors-drugmakers-share-blame-opioid-epidemic/86774468/;
accessed January 1, 2017.
12 Pallarito, Karen; Rising Price of Opioid OD Antidote Could Cost Lives: Study; Health Day News, December 8, 2016. https://
consumer.healthday.com/bone-and-joint-information-4/opioids-990/rising-price-of-opioid-od-antidote-could-costlives-717589.html;
accessed December 8, 2016.
13 Gupta, R., Shah, N. D., & Ross, J. S. (2016). The Rising Price of Naloxone � Risks to Efforts to Stem Overdose Deaths. New
England Journal of Medicine, 375(23), 2213-2215. doi:10.1056/nejmp1609578
14 Cha, Ariana Eunjung; The drug industry�s answer to opioid addiction: More pills, October 16, 2016;
www.washingtonpost.com/national/the-drug-industrys-answer-to-opioid-addiction-morepills/2016/10/15/181a529c-8ae4-11e6-bff0-d53f592f176e_story.html?utm_term=.1e48b2598deb;

accessed December 8, 2016.
15 Cha, Ariana Eunjung, 2016.
16 Shedrrofsky, Karma, 2016.
17 America�s Painkiller Epidemic, Explained; The Week, February 13, 2016;
theweek.com/articles/605224/americas-painkiller-epidemic-explained
18 Wing, Nick; DEA Is Cutting Production Of Prescription Opioids By 25 Percent In 2017; Huffington Post, October 5, 2016;
www.huffingtonpost.com/entry/dea-cutting-prescription-opioids_us_57f50078e4b03254526297bd
19 Mulvihill, Geoff, Whyte, Liz Essley, Wieder, Ben; Politics of pain: Drugmakers fought state opioid limits amid crisis; The Center
for Public Inegrity, December 15, 2016. www.publicintegrity.org/2016/09/18/20200/politics-pain-drugmakersfought-state-opioid-limits-amid-crisis;
accessed December 20, 2016.
20 Himani, A, Manohar S., Reddy, Gopal N., Supriya, P.; COMPARISON OF EFFICACY OF BUTORPHANOL AND FENTANYL AS INTRATHECAL
ADJUVANT TO BUPIVACAINE, Journal of Evolution of Medical and Dental Sciences;
jemds.com/latest-articles.php?at_id=7552; accessed December 31, 2016.
21 CDC: 10 Most Dangerous Drugs Linked to Overdose Deaths, Health Day, December 22, 2016. www.empr.com/
news/cdc-10-most-dangerous-drugs-linked-to-overdose-deaths/article/580540/; accessed January 1, 2017.
22 Mulvihill et.al.., 2016.
23 Mulvihill et.al.., 2016.
24 Mulvihill, et. al., 2016.
25 Cha, Ariana Eunjung, 2016.
26 Cha, Ariana Eunjung, 2016.
�2017 Foundation for Chiropractic Progress PAGE 27
27 Centers for Disease Control and Prevention. Web-based Injury Statistics Query and Reporting System (WISQARS). 2014
(www.cdc.gov/injury/wisqars/fatal.html).
28 Thompson, Dennis; Drug Overdose Deaths Climb Dramatically in U.S.; HealthDay News, December 20, 2016;
consumer.healthday.com/bone-and-joint-information-4/opioids-990/drug-overdose-deaths-climb-dramatically-inu-s-717988.html;
accessed December 23, 2016.
29 Bernstein, Lenny; Crites, Alice, Higham, Scott, and Rich, Steven; Drug industry hired dozens of officials from the DEA as
the agency tried to curb opioid abuse; The Washington Post, December 22, 2016; www.washingtonpost.com/
investigations/key-officials-switch-sides-from-dea-to-pharmaceutical-industry/2016/12/22/55d2e938-c07b-11e6-b527-
949c5893595e_story.html.
30 Siegel, Marc, MD; We doctors are enablers: A physician�s take on the opioid epidemic; FOXNews, December 21, 2016;
www.foxnews.com/opinion/2016/12/21/doctors-are-enablers-physicians-take-on-opioid-epidemic.html;
accessed January 4, 2017.
31 Freyer, Felice J.; Doctors are cutting opioids, even if it harms patients; Boston Globe, January 3, 2017;
www.bostonglobe.com/metro/2017/01/02/doctors-curtail-opioids-but-many-see-harm-pain-patients/z4Ci68TePafcD9AcORs04J/story.html.
32 Blair, Nolan; Doctors prescribing less opioids; ABC WBAY.com, November 2, 2016.
wbay.com/2016/11/02/report-finds-decrease-in-opioid-prescriptions/
33 Centers for Disease Control; www.cdc.gov/drugoverdose/pdmp/; accessed January 5, 2017.
34 Lord, Rich; Attention to opioids may be curbing doctors prescriptions; Pittsburgh Post-Gazette, December 26, 2016; http://
www.post-gazette.com/news/overdosed/2016/12/26/Attention-to-opioids-may-be-curbing-doctors-prescriptions/stories/201612260013
35 Nuzum, Lydia; Opioid prescriptions in US, WV down for first time in two decades; The Charleston Gazette-Mail, June 6, 2016.
www.wvha.org/Media/NewsScan/2016/June/6-6-16-Opioid-prescriptions-in-US,-WV-down-for-fir.aspx
36 Freyer, Felice J.; Opioid prescriptions drop among patients covered by state�s biggest insurer; Boston Globe, October 20,
2016; www.bostonglobe.com/metro/2016/10/20/opioid-prescriptions-drop-significantly-among-patients-covered-state-biggest-insurer/06jIYorfogaG2o8Wrhr8ZN/story.html
37 Freyer, Felice J., 2016.
38 U.S. Agency for Healthcare Research and Quality, Opioid Overdoses Burden U.S. Hospitals: Report, HealthDay News, December
15, 2016. consumer.healthday.com/public-health-information-30/heroin-news-755/opioid-overdoses-taketoll-on-u-s-hospitals-717872.html;
accessed December 16, 2016.
39 Reddy, S. (2017, February 13). No Drugs for Back Pain, New Guidelines Say. Retrieved from
www.wsj.com/articles/no-drugs-for-back-pain-new-guidelines-say-1487024168
40 Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: Relieving Pain in
America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press, 2011.
books.nap.edu/openbook.php?record_id=13172&page=1.
41 American Association of Neurological Surgeons; Low Back Pain, May 2016. www.aans.org/Patientpercent20Information/Conditionspercent20andpercent20Treatments/Lowpercent20Backpercent20Pain.aspx
42 American Academy of Pain Medicine; Facts and Figures About Pain;
www.painmed.org/PatientCenter/Facts_on_Pain.aspx#refer; accessed January 7, 2017.
43 Daniel C. Cherkin, Robert D. Mootz; Chiropractic in the United States: Training, Practice, and Research, 2010.
Chiropractic in the United States: Training, Practice, and Research�; accessed January 17, 2017.
44 Wong, J. J., Shearer, H. M., Mior, S., Jacobs, C., C�t�, P., Randhawa, K., . . . Taylor-Vaisey, A. (2016). Are manual therapies, passive
physical modalities, or acupuncture effective for the management of patients with whiplash-associated disorders or
neck pain and associated disorders? An update of the Bone and Joint Decade Task Force on Neck Pain and Its Associated
Disorders by the OPTIMa collaboration. The Spine Journal, 16(12), 1598-1630. doi:10.1016/j.spinee.2015.08.024.
45 Spinal Manipulation for Low-Back Pain. (2016, April 20). Retrieved January 17, 2017, from
nccih.nih.gov/health/pain/spinemanipulation.htm.
46 Wong, J., C�t�, P., Sutton, D., Randhawa, K., Yu, H., Varatharajan, S., . . . Taylor-Vaisey, A. (2016). Clinical practice guidelines for
the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management
(OPTIMa) Collaboration. European Journal of Pain, 21(2), 201-216. doi:10.1002/ejp.931
47 Doctor, Jason, October 4, 2016.
48 Goodrich, Kate, MD; Agrawal, Shantanu, MD; The CMS Blog; Addressing the Opioid Epidemic: Keeping Medicare and Medicaid
Beneficiaries Healthy, January 5, 2017; blog.cms.gov/2017/01/05/addressing-the-opioid-epidemic/
49 Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine.
2006;31(23):2724�7. doi:10.1097/01.brs.0000244618.06877.cd
PAGE 28 �2017 Foundation for Chiropractic Progress
CHIROPRACTIC � A KEY TO AMERICA’S OPIOID EXIT STRATEGY
50 Bureau of Labor Statistics; Nonfatal Occupational Injuries and Illnesses Requiring Days Away From Work, 2015,
November 10, 2016; www.bls.gov/news.release/osh2.nr0.htm; accessed January 8, 2017.
51 Lawlor, Joe; Back injuries most common type of injuries for workers; Portland Press Herald, October 16, 2016; www.
pressherald.com/2016/10/16/back-injuries-most-common-type-of-injuries-for-workers/; accessed 1.8.2017.
52 Lawlor, Joe; 2016.
53 Lawlor, Joe; 2016.
54 Blanchette, MA., Rivard, M., Dionne, C.E. et al. J Occup Rehabil (2016). doi:10.1007/s10926-016-9667-9;
link.springer.com/article/10.1007/s10926-016-9667-9.
55 Keeney BJ, et al. Early predictors of lumbar spine surgery after occupational back injury: results from a prospective study
of workers in Washington State. Spine 2013 May 15;38(11):953-64.
6 Dorr, Hannah and Townley, Charles; Chronic Pain Management Therapies in Medicaid: Policy Considerations for Non-Pharmacological
Alternatives to Opioids; National Academy for State Health Policy, September 2, 2016;
nashp.org/chronic-pain-management-therapies-medicaid-policy-considerations-non-pharmacological-alternatives-opioids/
57 It is important to note that the KFF data tracks which states allow direct reimbursement to the specific provider type (e.g.,
directly reimbursing a physical therapist for physical therapy services); states that do not directly reimburse these providers
may actually cover the service if billed by another provider (e.g., an institutional setting). For more information, please
see the notes in the following references.
Kaiser Family Foundation. �Medicaid Benefits: Physical Therapy Services.� Retrieved August 24, 2016.
kff.org/medicaid/state-indicator/physical-therapy-services/
Kaiser Family Foundation. �Medicaid Benefits: Psychologist Services.� Retrieved August 24, 2016.
kff.org/medicaid/state-indicator/psychologist-services/
Kaiser Family Foundation. �Medicaid Benefits: Occupational Therapy Services.� Retrieved August 24, 2016.http://
kff.org/medicaid/state-indicator/occupational-therapy-services/
Kaiser Family Foundation. �Medicaid Benefits: Chiropractor Services.� Retrieved August 24, 2016.
kff.org/medicaid/state-indicator/chiropractor-services/
58 Dagenais, S., Brady, O., Haldeman, S., & Manga, P. 2015, October 19. A systematic review comparing the costs of
chiropractic care to other interventions for spine pain in the United States. Retrieved February 08, 2017, from
www.ncbi.nlm.nih.gov/pmc/articles/PMC4615617/
59 Neighborhood Health Plan of Rhode Island Clinical Practice Guideline, Complementary and Alternative Medicine (CAM).
December 18, 2014.
60 U.S. National Institutes of Health; Assessment of Chiropractic Treatment for Low Back Pain and Smoking Cessation in Military
Active Duty Personnel; clinicaltrials.gov/ct2/show/NCT01692275; accessed January 8, 2017.
61 U.S. National Institutes of Health
62 Goertz, Christine M. DC, PhD, et. al; Adding Chiropractic Manipulative Therapy to Standard Medical Care for Patients With
Acute Low Back Pain: Results of a Pragmatic Randomized Comparative Effectiveness Study; SPINE, Volume 38, Issue 8,
April 15, 2013; journals.lww.com/spinejournal/Abstract/2013/04150/Adding_Chiropractic_Manipulative_Therapy_to.2.aspx
63 Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain � United States, 2016. MMWR
Recomm Rep 2016;65(No. RR-1):1�49. DOI: dx.doi.org/10.15585/mmwr.rr6501e1.
64 CBS News/AP. (2016, March 15). CDC guidelines aim to reduce epidemic of opioid painkiller abuse. Retrieved January 15,
2017, from www.cbsnews.com/news/opioid-painkiller-guidelines/.

Foundation For Chiropractic Progress�

BOARD OF DIRECTORS

Kent S. Greenawalt, CEO, Foot Levelers; Chairman of the Board of Directors, F4CP
Mickey G. Burt, DC, Executive Director of Alumni and Development, Palmer College of Chiropractic Gerard W. Clum, DC, Director, The Octagon, Life University
Kristine L. Dowell, Executive Director, Michigan Association of Chiropractors
Joe Doyle, Publisher, Chiropractic Economics
Charles C. Dubois, President/CEO, Standard Process, Inc.
J. Michael Flynn, DC
R. A. Foxworth, DC, FICC, MCS-P, President, ChiroHealthUSA
Arlan W. Fuhr, Chairman/Founder, Activator Methods International Ltd.
Greg Harris, Vice President for University Advancement, Life University
Kray Kibler, CEO, ScripHessco
Thomas M. Klapp, DC, COCSA Representative
Carol Ann Malizia, DC, CAM Integrative Consulting
Fabrizio Mancini, DC, President Emeritus, Parker University
Brian McAulay, DC, PhD
William Meeker, DC, MPH, President, Palmer College of Chiropractic � San Jose Campus
Robert Moberg, CEO, Chirotouch
Donald M. Petersen, Jr., Publisher, MPA Media
Mark Sanna, DC, FICC, ACRB, Level II, President, Breakthrough Coaching
Paul Timko, Vice President/General Manager of U.S. Clinical Business, Performance Health

Massage for Chronic Low Back Pain & Sciatica

Massage for Chronic Low Back Pain & Sciatica

Individuals with persistent low back pain can choose from a variety of proven nonsurgical treatments, including: medications, physical therapy, and exercise, to name a few. A 2017 study discussed another therapy for chronic low back pain and sciatica: massage.

In a first-of-its-kind study, researchers used a real world� strategy that was � compared to running the study in a managed setting.

More than 50 percent of the research participants reported, �clinically purposeful development� in their low back pain after their massage therapy plan, composed co-first authors William G. Elder, PhD, Family and Community Medicine at the University of Kentucky, and Niki Munk, PhD, LMT, School of Health and Rehabilitation Sciences at Indiana University-Purdue University Indianapolis.

�Clinical massage therapy appears to be effective for low back pain, and patients should discuss with their provider and consider clinical massage therapy before attempting highly debatable opioid drugs,� says Dr. Elder, who was the lead researcher of the study.

A Closer Look in the Study

The research team collaborated with primary care providers in Kentucky who referred patients for 10 massage sessions with licensed massage therapists in the community over a 12-week interval. The massage therapists crafted exceptional massage therapy recommendations on the foundation of the specific patient�s requirements.

The participants were measured before they began their massage program, in the close of the 12-week program, then at 24 weeks after the onset of system. At 12 weeks, 54.1 percent shown clinically significant development in their long-term low back pain. At 24 weeks, their development was kept by 75 percent of patients who demonstrated improvement at 12 weeks.

Some crucial insights related to drug regimen, and patients� age, weight were found by the researchers: Adults age 50 and over were more prone to possess significant progress inside their particular long-term low back pain as an outcome of massage therapy. The advantage didn�t hold, although heavy patients had great results from massage.

Patients who reported taking opioid pain drugs did report reduced pain as a result of the massage treatment, but they were two times not likely to have clinically significant change in comparison to patients not taking opioids.

While Dr. Munk, who is a licensed massage therapist, says she expected the patients to have favorable results from the course of massage treatment, some facets of the study results surprised her.

�I was a bit surprised the baby boomer generation was more likely to have better results,� Dr. Munk says.

Dr. Munk hypothesizes that old people may have a distinct perspective on pain tolerance. Since elderly individuals likely have had more time including every one of the state she also wonders if folks that are older might be more accustomed to living with pain and had heightened perceptions of pain alleviation.

Massage Drawbacks and Expectations

While the study suggests that massage could offer individuals with chronic low back pain with pain relief that is purposeful, it truly is not a fast repair. Dr. Munk says people should level-confirm their expectations by taking into consideration how long they�ve lived with their state when they go to their first massage.

�If you�ve had a state for 10-15 years, the chance that a one-hour session will fix it is probably not realistic,� Dr. Munk says.

Dr. Munk notes that massage, given its foundation as a muscle treatment, should be viewed as a care therapy�not a short term strategy.

The body goes back to routines its used to and has, and also �Muscle patterns grow to be retrained she says. � you also must take another dose for alleviation, and Like a pill that wears off after a couple of hours, it could take several sessions to get the job to �hold.��

Another consideration patients must understand is the cost of massage, as the treatment isn’t covered by most health insurance plans. Investing in massage is an individual decision that requires weighing pros and cons. If massage therapy can help you manage your chronic back pain without the significance of spinal column surgery or other treatments which can be more significant, you might find it’s worth the out of pocket price.

Tips on Making Massage Effective

In case your doctor recommends massage therapy, building a trusting and comfortable therapeutic relationship is significant. Request your doctor if he or she recommend a massage therapist in the locality.

Dr. Elder and Dr. Munk additionally propose asking the following questions to any prospective massage therapist before your first session:

  • Have you ever been a licensed massage therapist?
  • What kind of training and education have you ever received?
  • How long are you now practicing?
  • Would you work with other healthcare professionals?
  • Have you had further education in other illness-specific areas (like back and neck pain)?
  • Do you remain current on any specific medical conditions you focus on and improvement in the massage therapy field?

Persistent low back pain can take a crucial cost on your own own life. By good fortune, many nonsurgical treatments can help you manage the pain. The results with this particular study suggest massage is a legitimate decision to lessen pain while you could possibly believe massage is only a relaxing indulgence. Request your doctor if massage is a treatment worth investigating for the specified state.

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900 .�blog picture of a green button with a phone receiver icon and 24h underneath

By Dr. Alex Jimenez

Additional Topics: Lower Back Pain After Auto Injury

After being involved in an automobile accident, neck injuries and aggravated conditions, such as whiplash, are some of the most commonly reported types of injuries, due to the force of the impact. A study discovered, however, that the seat of a vehicle can often lead to injuries as well, causing lower back pain and other symptoms. Lower back pain is also among one of the most common types of automobile accident injuries in the U.S. alone.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: New PUSH 24/7�? Fitness Center

 

 

History of the Schroth Method for Scoliosis

History of the Schroth Method for Scoliosis

Scoliosis is a well-known spinal condition which results in an abnormal, often lateral, curvature of the spine. While most cases of the issue are reported among children and teens, adults can also experience scoliosis, later in their lives. Fortunately, non-surgical procedures, such as the Schroth method of exercises for scoliosis, were created to correct this spinal condition, improving the lives of many affected with scoliosis.

Katharina Schroth (1894-1985) developed the Schroth Method, based on her personal experience with spinal issues as a teenager. When Katharina was told she had scoliosis and would require surgery the system originated. Unwilling to possess surgery, she instantly began to formulate a way to place scoliosis in check plus it became her life�s work. She dedicated countless hours attempting different corrections of her curve and detected certain positions, movements and breathing techniques which made her own torso deformity clear.

Trained as a teacher, Ms. Schroth began sharing her techniques with patients in the 1920’s and finally created her own clinic in Germany. The Schroth Approach was established in Germany in 1921, by Katharina Schroth. This curve design particular scoliosis technique was refined through the years by the creator�s daughter, physical therapist Christa Lehnert-Schroth PT, and grandson and orthopedic doctor, Dr. Hans-Rudolf Weiss, at the inpatient practice bearing the name of Katharina Schroth set in Germany�s Rhineland. Her daughter, Christa Lehnert-Schroth P.T. immensely helped her further develop the theory underlying the Schroth Method. Katharina�s grandson, Dr. Hans-Rudolph Weiss, MD has continued the tradition by developing his own unique program called Scoliologic in Germany.

The Schroth Method Today

The Schroth Method continues to be practiced in Germany since then, and it is only in the last few years that the Schroth Method has spread all around the world as wait and scoliosis patients search for options to observe , bracing, and surgery for scoliosis treatment. The Schroth family has authored publications, created numerous posts, and taught others on these nonsurgical techniques. Although possessed by the Schroth family today, over one thousand patients are treated annually at Asklepios Katharina-Schroth Klinic in Germany and there’s frequently a several month long waiting list.

Clinical research shows that the approach can reduce spinal curvatures. Surely, the success also depends upon the commitment of the patients. Schroth exercises could be broadly divided into two types. They are the old in patient Schroth Intensive Rehabilitation along with the more recent outpatient Schroth Best Practice. The latter essentially consists of exercises to enhance corrective exercises the sagittal spinal curves and adoption of appropriate corrective bearings during daily actions.

The physiologic exercises aim at preserving the natural lumbar lordosis in sitting and standing positions.
Corrective exercises are scoliosis special exercises. They differ together with the curvature sorts. Rotational breathing is incorporated to the treatment, to improve the vertebral rotation.

Although there are many other popular forms of treatments available for scoliosis, including surgical interventions, the Schroth method has been recognized by many healthcare professionals and researchers due to their effectiveness in treating the spinal condition in children, teens and even adults. Be sure to consult a qualified and experienced healthcare specialist regarding the best treatment method for scoliosis and/or seek a doctor/physician who has knowledge on the specific exercises of the Schroth method for scoliosis treatment.

Schroth Method Exercises for Scoliosis

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900blog picture of a green button with a phone receiver icon and 24h underneath

By Dr. Alex Jimenez

Additional Topics: Lower Back Pain After Auto Injury

After being involved in an automobile accident, neck injuries and aggravated conditions, such as whiplash, are some of the most commonly reported types of injuries, due to the force of the impact. A study discovered, however, that the seat of a vehicle can often lead to injuries as well, causing lower back pain and other symptoms. Lower back pain is also among one of the most common types of automobile accident injuries in the U.S. alone.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: New PUSH 24/7�? Fitness Center

 

 

The Effectiveness of the Schroth Method for Scoliosis

The Effectiveness of the Schroth Method for Scoliosis

A very few number of research studies have been conducted to examine how effective the Schroth method is towards the management of scoliosis, particularly in countries such as the United States, where the duration of therapy programs are generally constrained to an average of 1 to 3 sessions.

Researchers conducted a study on a 26 year old female with adolescent idiopathic scoliosis in order to examine the effects of Schroth therapy. The physical therapy regimen included a 1-hour Schroth method session of exercises, twice per week for four weeks, followed by one session of the Schroth therapy each week for 20 additional weeks. Furthermore, the research study also included a home exercise program which consisted of 30-minute sessions, five days per week. All evaluation measurements and results were recorded before and after the treatment.

After a 6-month treatment period, the patient had experienced a significant and measurable improvement of symptoms as well as the overall condition. Additionally, the patient was satisfied with their results, reporting improved bodily strength and she felt more comfortable with her appearance.

The findings of the research study suggest that scoliosis treatment utilizing the Schroth method and it’s specific exercises may be an effective treatment option for the spinal condition to the traditional methods of treatment and rehabilitation.

Researchers also conducted another study to compare the effectiveness of Schroth method exercises in other patients with adolescent idiopathic scoliosis. Designed as a randomized-controlled study in an outpatient exercise-unit and in a home setting, the research study consisted of fifty-one patients who were diagnosed with adolescent idiopathic scoliosis or AIS. Forty-five of the patients with adolescent idiopathic scoliosis whom met the inclusion criteria were divided into three groups. The Schroth method exercises were applied to the first group in the clinic, which were also given to the second group as a home regimen and the third group was the control group.

The findings of the research study demonstrated an improvement of the condition and its symptoms in the clinic Schroth method exercise group compared to the other groups. According to the results, the waist asymmetry improved only in the clinic exercise group where the results of the other groups worsened. In conclusion, the Schroth exercise program was effective towards improving scoliosis and its symptoms.

How to Treat Scoliosis – About the Schroth Method

 

The scope of our information is limited to chiropractic and spinal injuries and conditions. To discuss options on the subject matter, please feel free to ask Dr. Jimenez or contact us at 915-850-0900blog picture of a green button with a phone receiver icon and 24h underneath

By Dr. Alex Jimenez

Additional Topics: Neck Pain and Auto Injury

After being involved in an automobile accident, the sheer force of the impact can often cause whiplash, a common type of neck injury resulting from the sudden, back-and-forth motion of the head against the body due to a car wreck, or other incident. Because of this, many of the complex structures found within the neck, including the spine, ligaments and muscles, can be stretched beyond their normal range, causing injury and painful symptoms.

 

blog picture of cartoon paperboy big news

 

TRENDING TOPIC: EXTRA EXTRA: New PUSH 24/7�? Fitness Center